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ABSTRACT
GENETIC AND STRUCTURAL ANAYLYSIS OF P22 LYSOZYME
P22 lysozyme , encoded by gene 19, is an essential phage
protein responsible for hydrolyzing the bacterial cell wall
during lytic infection. P22 lysozyme is related to T4 lysozyme
in its mode of action, substrate specificities , and in its
structure. Gene 19 was located on the phage genome , subcloned
and then sequenced. Lysozyme was produced in large quanti ties
and purified for biochemical characterization and for
crystallograpic studies. Gene 19 consists of 146 codons , and
encodes a protein with a molecular weight of 16 117.
Amer mutations were created in gene 19 by in vitro
primer-directed mutagenesis. The mutations were crossed by
homologous recombination onto the phage genome. The phages
bearing the amber mutations in gene 19 were screened for the
ability to grow on six different amber suppressor strains. Amino
acid substitutions that resulted in nonfunctional or less
functional lysozyme were determined. Of 60 possible amino acid
substitutions at 11 different sites in P22 lysozyme , 20 are
deleterious. The phage bearing amber mutations in gene 19 that
failed to grow on given suppressor strains were reverted and
second site intragenic revertants were obtained. The mutations
were sequenced.
A substitution of serine for glutamine at residue 82 is
compensated for by changing residue 46 from serine to leucine.
This single change enables the phage to form a plaque at 30 C but
not at 40 C. When the triple change asn42- lys; ser46- leu; and
ser43- pro is present the lysozyme produced is no longer
temperature sensi ti ve. The crystal structure of P22 lysozyme is
not yet solved. Assuming that the structures of T4 lysozyme and
P22 lysozyme are similar , one can examine the positions of
equivalent residues in the T4 lysozyme structure. The spatial
arrangement of the residues changed by the secondary site
mutations and the original substitution can then be visualized.
The mutations discussed above all map far from the original
mutation on the T4 three dimensional model.
A substitution of leucine for tyrosine at position 22 is
compensated for by the double mutation of arg18- ser and ser23-
lys . When the equivalent residues are mapped on the T4 three
dimensional model the changes map in close proximity to the
original mutation.
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INTRODUCTION
The Question of How a Protein s structure is Determined
An intriguing question for biologists for decades has
been how a protein assumes its tertiary structure. In the
1930' s , Corey and Pauling started x-ray crystallographic
studies of amino acids and polypeptides to obtain a set of
standard bond distances and angles for amino acids and small
peptides. By 1951, before a complete amino acid sequence had
been determined for any protein, they were ab c to predict
that given the conformations that peptide bond-linked amino
acids could assume , alpha helixes and beta-pleated sheets
could be structural elements of proteins. In 1953 , Fredrick
Sanger determined the amino acid sequence of insulin. This
was the first demonstration that a protein has a precisely
defined amino acid sequence. Once amino acid sequences were
elucidated, it was hoped that the structures of proteins could
be predicted. The famous studies of Haber and Anfinsen on the
denaturation and renaturation of bovine ribonuclease showed
conclusively that all the information needed to obtain the
proper structure was contained in the primary amino acid
sequence. This laid to rest a hypothesis that some type of
biological template determined the structure that a protein
would assume. This discovery did not simplify the task of
predicting structures though, since in a simple protein of
just 166 amino acids there is estimated to be 1 x 10
possible conformations if each residue could assume three
different conformations (Levinthal , 1968). since proteins
have precisely determined amino acid sequences, and the unique
structures of every protein must be related to the amino acid
sequence, the question became how amino acid sequences dictate
structures.
Background. In 1964, Davies tried to correlate the
amino acid composition of 15 proteins and the alpha helix
content of each protein to predict how amino acid composition
affected alpha helix content. This was done at a time when
the crystal structure and amino acid sequence of only one
protein was known: sperm whale myoglobin. The hel ix content
for the rest of the proteins was determined by their optical
properties in aqueous solution. By statistical methods , he
was able to correlate low helix content with high mole
percentage of the following amino acids: serine , threonine
valine, isoleucine, and cysteine. He determined that when
these amino acids constituted greater than 25% of the
protein' s amino acids they somehow destabilized helixes
(Davies, 1964). Many statistical predictive methods for
determining a protein' s secondary structure from amino acid
sequences have been published (Chou and Fasman, 1974a,
Garnier et al., 1978; Lim , 1974a b; Robson and Pain 1974a
Kabsch and Sander, 1984; Cohen et al., 1983). These algorithms
have been formulated based on the availability of protein
sequences and the co-ordinates of crystal structures. Even
today, the amount of knowledge about the crystal structure of
proteins is limited by the number of structures that have been
solved. The Protein Information Resource Data Bank contains
about 6000 protein sequences but the Brookhaven data bank
contains co-ordinates of only 300 different protein structures
of which only about 100 are for nonhomologous proteins
(Blundell et al., 1987 Claverie and Bricault , 1986). Even
though the predictive accuracy of these algorithms has
increased , we still do not know how particular secondary
structures will align themselves in relation to one another to
obtain the tertiary structure. To date a tertiary structure of
a protein has not been accurately predicted (Ponders and
Richards, 1987). Attempts have been made (Levitt and Chothia,
1976) to categorize groupings of secondary structures into 4
classes. The authors used schematic two-dimensional
representations termed topology/packing diagrams. The proteins
fall into four classes, which are designated; (I) all-helix,
(II) all-beta, (III) helix + beta (contains helixes and beta
structures that do not mix but tend to segregate along the
polypeptide chain), (IV) helix/beta (contains mixed or
approximately alternating segments of helical and beta-strand
secondary structure).
Folding Pathways. Some methods for predicting protein
structure are based on thermodynamics. That a protein folds
by a limited number of pathways rather than searching randomly
through all possible conformations was recognized early on
since the amount of time that a random trial and error method
would take is inconsistent with observed time of synthesis of
native proteins ( Anfinsen, 1973; Levinthal, 1968; Wetlaufer,
1973) . Two models dominate the field today. The first is
random search nucleation and chain propagation. This
hypothesis states that nucleation centers in an unfolded
polypeptide chain would initiate the folding process and
direct it to a kinetically favorable pathway (Wetlaufer, 1973;
Lewis et al., 1971; creighton, 1974). The nucleation center
is postulated to be between 8 and 18 residues in length. The
difficulty with this model is once the nucleation center is
formed the rest of the residues in the polypeptide chain must
search randomly to sample which conformation is most
thermodynamically stable. The second working model of protein
folding is the diffusion collision theory of Karplus and
Weaver (1979). This states that local native-like structures
form "microdomains" which diffuse and collide with other
microdomains and coalesce into the native structure. The
authors do not feel that there is any given order to
coalescence of the microdomains. Levitt and Chothia (1976)
found that secondary structural elements represented in their
topology/packing diagrams that are adj acent along the
polypeptide chain are also in three dimensional contact more
often than secondary elements that were not adj acent along the
polypeptide chain. This would seem logical given the
diffusion and collision model since the microdomains formed
from adj acent residues would be clos.est.
Harrison and Durbin (1985) make an analogy between
protein folding pathways and assembly of a jigsaw puzzle.
hey feel that the diffusion, collision theory fits most
experimental data and that there is no one discrete pathway to
a final structure. Sometimes a local secondary structure will
form first while at other times another will. If incorrect
structures coalesce with one another then the complex will
fall apart due to lack of stabilization by other secondary
structures. They feel it is this internal editing rather than
a pathway defined by the amino acid sequence , that makes
folding nonrandom.
Protein Mutants. An important prediction of
Harrison and Durbin is that mutants kinetically blocked in any
given pathway will have alternative . pathways available so it
will be unlikely to find any protein folding mutations.
Apparent contradictions to this prediction would be mutations
isolated as tss 
(temperature sensitive for synthesis).
Temperature-sensi ti ve mutant proteins when formed at
permissive temperature and then exposed to nonpermissive
temperatures behave normally (streisinger et al., 1961).
was thought that such mutants represented folding 
mutations,
since it was only during synthesis that high temperature was
detrimental. There are many examples of tss mutants (eg. 
coli lacI, Sadler and Novick, 1965; P22 tail protein, 
King,
1987) . Harrison and Durbin note that tss mutations have been
found only in proteins that undergo oligomerization or
assembly into a functional unit, and speculate that these
mutations are not folding mutations but assembly mutations. If
their model is correct then mutations that kinetically block
folding will not be isolated.
The study of protein mutants has yielded much
information on the chemistry of active sites of 
enzymes. Yet
information about how the three dimensional structures form
and are maintained has been harder to obtain. Mutant 
proteins,
particularly those that exhibit a change in stability are
being studied to determine how final structures of proteins
are stabilized. This might be the only route to decipher how
amino acid sequences dictate structures if, as Durbin and
Harrison propose, true folding mutations will not be 
found.
Matthews and colleagues (1987) are examining mutations that
affect the stability of protein structure. For instance, they
reasoned that a decrease in configurational entropy of the
unfolded state would stabilize the protein toward reversible
and irreversible thermodenaturation. They reasoned that it
takes more free energy to hold a glycine residue in a given
conformation than it does to maintain an alanine residue since
glycine lacks a beta-carbon and has more backbone
conformational flexibility than alanine. By replacing glycine
77 with an alanine they were able to "enhance T4 lysozyme'
thermostabil i ty . other investigators are attempting to
increase protein stability by adding disulfide bonds. This has
been tried with T4 lysozyme (Perry and Wetzel, 1984),
dihydrofolate reductase (Villafranca et al., 1983),
ribonuclease A (Lin et al., 1984), chicken lysozyme (Udea et
al., 1985), and bacterial protease subtilisin BPN' (pantoliano
et al., 1987). Mutations such as these which enhance protein
stability do not really address the question of protein
folding since these mutations result in a larger free energy
difference between the folded and unfolded protein and
therefore a more stable protein would be expected to result
unless the new disulfide bonds interfered in some other
interaction in the final structure.
Nearly 100 mutant human hemoglobins have been
characterized. The mutants were examined in conjunction with
an atomic model of hemoglobin based on x-ray analysis of horse
hemoglobin (perutz and Lehmann, 1968). It was found that the
molecule was extremely sensitive to changes of internal non-
polar contacts , especially those near the hemes. The molecule
was relatively insensi ti ve to replacements of most amino acid
residues on its surface. studies such as these allowed one to
understand some of the interactions that take place in the
tertiary structures.
T4 lysozyme mutants have also been studied in detail
(Alber et al., 1987a, b; Matthews et al., 1987; Streisinger et
al, 1961) with the crystal structures solved for a large
number of the mutant proteins. Information obtained from
these studies has allowed investigators to formulate some
generalities. For instance in studying temperature sensitive
mutations in T4 lysozyme the investigators determined that
most of the mutations that affected the stability of the
protein were at sites with low mobility and low solvent
accessibility in the folded protein (Alber et al. , 1987).
Another example of mutations whose primary defects are
destabilization of the tertiary structures are Cro repressor
mutants that have been recently lsolated (Pakula et al.,
1986). Some of the cro repressors that had decreased stability
had nearly normal specific activity. The half life of the
molecules was drastically reduced. These were cases where a
protein was able to fold but the equilibrium between the
folded state and the unfolded state was changed so that the
protein spent more time in the unfolded state. Most of these
mutations affected residues in the tightly packed protein
interior.
second site Revertants. The question of how
amino acid sequences determine structures has proved to be
hard to approach by genetics. Part of the problem might be
that the mutant proteins studied have been only slightly
defective. By this I mean that if the protein had a severe
mutation that prevented it from folding into a proper
structure then that protein would probably never be isolated
since denatured proteins are often attacked by proteases and
degraded rapidly. The use of second site revertants might
overcome this difficulty. using second site revertants for
studying proteins is not a new idea. Helinski and Yanofsky
described studies of second site revertants of the A protein
of E. coli tryptophan synthetase in 1963. using genetic
analysis and peptide mapping they were able to determine that
a second site intragenic change of a tyrosine to a cysteine
would compensate for an original mutation that substituted
glutamic acid for glycine. This second change when isolated
from the original mutation yielded a functionally ineffective
A protein. It was also an allele specific suppressor since it
failed to suppress several other A protein mutations,
including a change of glycine to arginine at the site of the
original mutation. since it was known that several amino
acids could substitute at the position of the original
mutation with no loss of function, it is thought that the
mutation probably affected the protein' s three dimensional
structure and did not change the residues in the active site
because substitutions are not often found in an enzyme'
catalytic site.
Second ite revertants have also been isolated in
staphylococcal nuclease A (Shortle and Lin, 1985). They have
characterized three intragenic "global suppressors" of
nuclease-minus mutations. A global suppressor is a mutation
which is capable of suppressing the nuclease-minus phenotype
of different alleles. It was postulated that these mutations
increased the stability of the protein, thus
overcoming a decrease in protein stability introduced by the
original nuc- mutations.
Double mutants were also utilized by Carter et al.,
(1984) to determine the structural effect of a primary
mutation that increased the affinity of tyrosyl tRNA
synthetase for ATP. They were able to determine that the
original mutation acted by distorting the polypeptide
backbone, thus altering the interaction of the side chain of
another residue with the substrate ATP.
Second site revertants have also been used to
investigate the interactions between proteins, and between
proteins and DNA (Jarvik and Botstein, 1973; Hochschild et
ale , 1983; Youderian et al., 1983; Gardella, pers. comr.
The use of second site reversion could allow for the
characterizatio of protein mutants that might not be
obtainable by other means. For instance, if a primary
mutation created a protein that was insoluble or degraded that
molecule would be unavailable for detailed 
analysis, but if a
second site mutation, which compensated for the original
defect, allowed a protein to fold it could be 
characterized.
Then by examining the double mutant one might be able to
deduce the defect of the single mutant. second site
revertants also allow one to determine which amino acids
within the protein interact with one another either directly
or indirectly.
There are several technical problems associated with
the isolation of large numbers of second site revertants
however: first, there is the task of distinguishing second
site revertants from primary site revertants; second
, if one
wishes to study interactions that take place wi 
thin the
protein one must be sure that the second site revertants are
intragenic; and third, since second site revertants might be
fairly rare you need to have a strong selection for reversion
events.
Scheme for isolating second site revertants of
missuppressed amer mutations in P22 lysozyme. Bacteriophage
P22 lysozyme presented a nice system in which to isolate
second site revertants. First, P22 is a genetically pliable
organism; it can undergo homologous recombination at high
frequency, it can effect the transduction of plasmid or
bacterial genomes, and it can be grown lysogenically or
lytically. Second, P22 lysozyme has several useful properties
for this type of study. It is a small protein with a
molecular weight of about 16, 000 but large enough to have a
two domain structure. The gene encoding P22 lysozyme consists
of only 438 bases so it is easy to sequence mutations. It is
monomeric, and apparently does not interact with other
proteins. This makes it unlikely that second site revertants
will be in other genes. P22 lysozyme is easily assayed in
vitro, permitting quantitative studies of mutant proteins.
is an essential P22 gene for lytic growth, but phage lacking
lysozyme function can be propagated as prophage and recovered
after induction by lysing the cells artificially, or by
complementing the phage with another source of lysozyme.
conditional essentiality of the gene makes selection of
The
revertants simple.
The approach I took was to create primary mutations in
P22 lysozyme and then isolate second site revertants that
compensated for the original mutations. The primary mutations
were missuppressed amber mutations. I use the term
missuppressed" to designate amber mutations that, when placed
in a strain containing a particular amber suppressor, yield a
nonfunctional or less active protein. The amber mutations were
created by oligonucleotide-directed mutagenesis by using
a plasmid-borne lysozyme gene as template. When the amber
mutations had been identified on the plasmid, the mutant genes
were transferred to P22 by homologous recombination, this step
was facilitated by setting up a strong selection for the
recombinant phage. The resultant phage bearing amber mutations
were plated on six amber suppressor strains to determine the
suppression patterns. Each amber mutation thus allowed me to
determine the affect of five or six single amino acid
substitutions . Missuppressed ambers, that is phage bearing
amber mutations, when grown on particular suppressor strains
produce nonfunctional lysozymes, were reverted. The
revertants were screened to determine if they were primary or
secondary site revertants. This screen is a simple one due to
the nature of the primary mutation. If an amber mutation
undergoes any change it is no longer an amber, therefore any
revertant that is capable of growing on a suppressor-minus
strain, by definition is a primary site revertant. The
mutations present in the secondary site revertants were
sequenced.
CHAPTER II
PHAGE P22 LYSIS GENES: NUCLEOTIDE SEQUENCES AND
FUNCTIONAL RELATIONSHIPS WITH T4 AND LABDA GENES
This chapter was published as a paper (Rennell , Dale
and Poteete, A.R. (1985). Phage P22 Lysis Genes: Nucleotide
Sequences and Functional Relationships with T4 and Lambda
Genes. Virology 143, 280-289). A. R. Poteete constructed pTP163
and pTP82 and observed that these plasmids would complement a
lysozyme minus P22 phage. I carried out all the other work
described in this and subsequent chapters.
CHAPTER I I
PHAGE P22 LYSIS GENES: NUCLEOTIDE SEQUENCES AND
FUNCTIONAL RELATIONSHIPS WITH T4 AND LABDA GENES
Introduction
Salmonella phage P22 has two genes that are essential
for lysis of the bacterial cell wall, genes 13 and 19
(Botstein et al., 1972). P22 gene 13 is similar to Lambda gene
S. P22 13- shows the same phenotype as Lambda failure to
lyse , production of viable phage for many hours past normal
lysis time , and continued production of lysozyme which can be
released by artificially disrupting the cells. Gene 13 and
gene map in analogous positions in their respective phage
genomes, between genes involved in late regulation and DNA
encapsulation. Presumably 13 protein acts like S protein , by
disrupting the cell membrane , thereby giving hydrolytic
enzymes access to the cell wall (Reader and Siminovitch
1971). This type of activity is also characteristic of the
product of T4 gene , t (Josslin, 1970).
P22 gene 19 encodes a protein that has cell wall
hydrolyzing activity. A 19- phage fails to lyse the host cell
but produces viable phage. A prominent cell wall hydrolyzing
activity present in cells infected with P22 wild type is
missing or altered in cells infected with phage bearing
mutations in gene 19 (Botstein et al., 1972). Rao and Burma
(1971) studied this activity and found that it has substrate
specificities like those of T4 lysozyme. They concluded that
the P22 enzyme is a lysozyme. T4 lysozyme, the product of
gene e, works by hydrolyzing Beta-1, 4 glycosidic bonds between
alternating units of N-acetylglucosamine and N-acetyl muramic
acid in the peptidoglycan (Tsugita et al., 1968). Lambda has
two proteins responsible for the cell wall hydrolyzing
activity found in phage-infected cells: a transglycosylase,
the product of gene R; and an endopeptidase , the product of
gene RZ. The R and Rz proteins together are known as lambda
endolysin (Bienkowska-Szewczyk and Taylor, 1980).
Phage lysozymes are particularly accessible to study
by physical and genetic techniques because of two
characteristics. First, lysozymes are small proteins with an
easily assayable acti vi ty . Sec nd , it is easy to obtain and
characterize mutant phage with altered lysozymes. These
advantages have been exploited in the study of T4 lysozyme.
Comparative studies of the three dimensional structures of
wild type and mutant T4 lysozymes have considerably enhanced
our understanding of lysozyme catalysis (Grutter and Matthews
1982) .
studies comparing T4 lysozyme with other lysozyres
have been informative. For example, it has been found that the
three dimensional structures of lysozymes are highly
conserved, but the amino acid sequences are extremely
variable. Even though T4 lysozyme and hen egg white lysozyme
(HEWL) have non-homologous sequences, key regions of their
three dimensional structures are superimposible (Rossman and
Argos , 1976; Levitt and Chothia, 1976; Remington and Matthews,
1978) . The similar activities of P22 and T4 lysozyme
encourage further studies comparing the two phage lysozymes.
Our assumption, confirmed by results described below, was that
the genetic non-relatedness of the two phages would preclude a
high degree of sequence homology between the T4 and P22
lysozymes. Hence we are dealing with proteins of dissimilar
primary structure that are closely related in function.
We present in this paper the results of experiments
that locate gene 3 and gene 19 on the chromosome of P22 and
determine their DNA sequences. In addition, we show that
plasmids that express T4 lysozyme , P22 lysozyme or lambda
endolysin can complement both P22 19- and lambda Thus
these functions are in a sense interchangeable.
Material and Methods
Media, buffers, and enzymes. LB broth, LB agar, M9CAA
soft agar, and DNA buffer were as described previously
(Poteete, 1982) RB is 50 mM TrisHCl pH 7. 2, 100 mM NaCl', 1 mM
EDTA, 3 mM 2-mercaptoethanol, and 10 percent glycerol (v Iv) .
TN25 is 50 mM TrisHCl pH 7. 5, 1 mM EDTA , 1. 4 mM 2-
mercaptoethanol , 5 percent glycerol (v Iv), and 25 mM NaCl.
Restriction endonucleases , T4 DNA ligase, T4
polynucleotide kinase and E. coli DNA polymerase I large
fragment were purchased from New England Biolabs.
Polyethylenimine was purchased from Sigma. Amonium sulfate
(special enzyme grade) was purchased from Schwarz Mann/Inc.
strains. E. coli strain W3110 lacIQ L8 (Brent and
Ptashne , 1981) was generally used for propagating plasmids and
for infections by lambda. C600 was the su+ E. coli strain
used. Salmonella strains DB7000 (leuAam414 SupO) , MS1363
(leuAam414 supE) , and MS1868 (leuAam414 r-m+ supO) are
derivatives of Salmonella typhimurium 
LT2.
P22 13-amH101 cl-7 was the source of P22 DNA for most
plasmid constructions. P22 19-amber strains were 19-amN111
c2, 19-amH447 cl-7, 19-amHl162 cl-7, 19-aml164 
cl-7, 19-
amH1239 1-7, 19-amH1365 cl-7, and 19- am1026 cl-7. Lambda
strains used were lambda R-am5, lambda cI-857 S-am7 and lambda
KH54 (cI del). T4 DNA for plasmid constructions was from
lambda-EIII e+ hybrid phage (Owen et al. , 1983).
Plasmids. Descriptions of the plasmids constructed
for these studies are in Table 1 and Fig. General methods
used for plasmid construction were as described previously
(Poteete and Roberts , 1981). E. coli and Salmonella
transformations and plasmid DNA preparations were carried out
as described previously (poteete, 1982).
DNA sequencing. Methods for DNA sequencing were as
described by Maxam and Gilbert (1980). The plasmids pTP163,
pDR102, pDR103, pDR100 and pDR101 were used as sources of
fragments for sequencing wild type gene 19 and part of gene
13. The wild type sequence for gene 13 was obtained from DNA
fragments isolated from pDRl17. Complete sequences of both
strands of DNA for gene 13 and 19 were determined. All
segments of sequence were ordered by direct overlap (Fig. 2).
Partial sequences of one strand of each mutant were
determined. The DNA fragments for the mutant sequences came
from plasmids pDR110, pDRl13, and pDRl14. The fragments were
purified using the method of Hansen ' (1981) .
Lysozyme assays. Lysozyme activity was determined by
decrease in turbidity of CHCl -treated E. coli measured by
absorbance at 470 nm as described by Rao and Burma (1971).
The lysozyme purification was also monitored by discontinuous
SDS-polyacrylamide gel (13 percent) electrophoresis (Laemmli,
1970) . Following electrophoresis , gels were stained with
Coomassie blue.
Protein purification. P22 lysozyme was purified from
MS1868 infected with P22 13-amH101 cl-7. The cells were grown
in 2 liters of LB broth to 1 x 108 cells/ml , phage was added
at a multiplicity of 10 and the culture was aerated at 30
for 3 hours. The cells were centrifuged at 6000 rpm for 10
minutes in a Sorvall GSA rotor. The cell pellet was
resuspended in 30 ml RB then frozen at -20 C overnight. The
frozen cells were placed in a 37 C water bath until thawed and
put on ice. All subsequent steps were carried out between 0
and 4 C. The cells were sonicated with four bursts of 10
seconds duration. It was determined by microscopy that the
suspension had less than 1 percent of the original cell count
that failed to lyse. The lysate was centrifuged at 40 000 rpm
for 90 minutes in a Beckman 70. 1 Ti rotor; 20 ml of RB was
added to the supernatant , and polyethyleieimine was added to a
final concentration of 0. 6 percent. The mixture was stirred at
C for 45 minutes and then centrifuged at 7000 rpm for 30
minutes in a Sorvall SS 34 rotor. Most of the lysozyme
activity was in the supernatant. Amonium sulfate was added
to 90 percent saturation and the mixture was stirred overnight
at 4 C. The precipitate was pelleted by centrifugation at
15, 000 rpm for 90 minutes in a Sorvall SS 34 rotor. The
pellet contained the majority of the lysozyme activity. The
pH was monitored thoughout the preceding steps and was always
in the range of 7. 0 to 8. 0. The pellet was redissolved with 2
ml TN25. The solution was applied to a 46 cm x 1. 5 cm column
of G-50 SF sephadex which was then developed with TN25; 4 ml
fractions were collected. The lysozyme activity was in one
peak between the void and included volumes. Pooled peak
fractions when examined by SDS polyacrylamide electrophoresis
showed only four major bands. The sample was then applied to a
15 cm x 1. 5 cm column of DEAE cellulose. The lysozyme was in
the flow-through fraction and judged to be 90 percent pure by
SDs-polyacrylamide gel electrophoresis: one other minor band
could be seen with Coomassie blue stain when 1. 5 micrograms of
protein were applied to the gel.
To prepare the sample for amino acid sequence
analysis it was concentrated with a membrane concentrator
(Millipore immersible CX-10) and then applied to a G
Sephadex column that was developed with 0. 1 M ammonium
bicarbonate. The peak containing the activity was then
lyophilized. The yield was 0. 04 mg of lysozyme as judged by
optical density at 280 nm. (We estimate that a 1 mgjml
solution of P22 lysozyme would have an A280 of 0. 837, based on
its amino acid composition as revealed by the DNA sequence).
Harker Rescue Experiments. Gene 19 was located on the
physical map of P22 by Rutila and Jackson (1981). To localize
the gene further, we carried out marker rescue experiments
strain MS1868 bearing
plasmids to be tested was grown to 2 x 10 cells/ml and plated
with lambda soft agar on LB plates containing 20 
g/ml
with plasmids described in Table 
ampicillin. Dilutions of the 19-am P22 phages were spotted
and plaque formation was noted. To obtain more quantitative
results plating efficiencies were determined (see Table 2).
From the results in Table 2 gene 19 was located on a 1100 bp
HpaI restriction fragment (shown in Fig. 1). The HpaI fragment
can be divided into two nearly equal parts by cleavage at a
NaeI site shown in Fig. Plasmids were constructed that had
either the right or left half of the HpaI fragment. Five 19-
amber alleles that were known to occupy different sites in the
gene (unpublished results) were used in these marker rescue
experiments. All the alleles could be rescued by plasmids
containing the entire HpaI fragment while two alleles could be
rescued from plasmids containing the right half and the other
three alleles could be rescued from plasmids containing the
left half of the HpaI fragment.
Resul ts
Sequences of Genes 13 and 19. The DNA sequence of a
1188 bp segment of the P22 chromosome known to contain gene 19
(see Methods) was determined. The sequence is, shown in Fig. 
There are only two open reading frames present in the sequence
large enough to encode for gene 13 whose protein product has
an estimated molecular weight of 10 500 (Youderian and
Susskind, 1980) and for gene 19 whose protein product has an
estimated molecular weight of 15, 000 (Youderian and Susskind
1980) to 20, 000 (Rao and Burma, 1971). Translated rightward
(with respect to the map in Fig. 1), the first large open
reading frame is gene 13. This gene starts with a single ATG
and terminates with a single TAA. It consists of 108 codons
and potentially encodes a protein with a molecular weight of
11, 520. The last six sense codons of gene 13 overlap the
first codons of gene 19 in a different reading frame. Gene 19
starts with two tandem ATG codons and terminates with a single
TGA. It consists of 146 codons and potentially encodes a
protein with a molecular weight of 16, 117.
The open reading frames depicted in the figure
represent gene 13 and gene 19 according to the following
observations. (1) Marker rescue experiments described in the
Methods section show that gene 19 is contained within the
region sequenced. Moreover, the gene straddles the NaeI site
as predicted by the marker rescue experiments. (2) Amer
mutants of gene 13 and gene 19 result in TAG codons in the
open reading frames identified for the respective genes.
also sequenced the h21 mutation of gene 13. This mutation is
used as a morphological marker since it changes plaque
morphology on green plates (Botstein et al., 1972) Youderian
and Susskind (1981) showed that the protein product of gene
13-h21 has an altered electrophorectic mobility on SDS
polyacrylamide gels. The sequence shows the change to be a G
to T in the third base of codon 57 of gene 13. This change
causes a substitution of cysteine for trytophan (see Fig. 3).
(3) The amino acid sequence of purified P22 lysozyme agrees
with that predicted by the DNA sequence. Lysozyme was
purified from phage-infected cells by procedures outlined in
the Methods section. The amino acid sequence was determined
for the first 33 residues of the amino terminal end. This
amino acid sequence shows that the protein begins with a
single methionine residue. The data concerning the rest of
the sequence (not shown) is consistent with that shown in Fig.
The protein product of gene 13 is basic; it contains
13 basic residues (Lys, His, Arg) and 8 acidic residues ,(Asp,
Glu) . The predicted hydrophobicity of the protein was
examined by the methods of Cantor and Schimmell (1980). The
results of these calculations are called "z" values. Z values
of 0. 11 are indicative of an intrinsic membrane
protein. The Z value of 13 protein is . 4362 which suggests an
intrinsic membrane protein.
The protein product of gene 19 has a molecular weight
of 15, 968 (the difference from the molecular weight predicted
from the DNA sequence is due to the absence of the first
methionine encoded in the DNA sequence from the mature
protein). This is in agreement with the electrophoretic
mobility of the purified protein in a 13 percent SDS
pQlyacrylamide gel, where it migrates slightly behind HEWL (MW
14, 600) (not shown). P22 lysozyme is a basic protein,
containing 21 basic residues and 14 acidic residues. The basic
character of the protein is apparent in its chromatographic
behavior: it binds to carboxy methyl cellulose at pH 7. 5 and
flows through DEAE cellulose at pH 8. 0 in low salt.
comparison of Lysis Functions of P22, Lamda and T4.
Bacteriophages T4, lambda, and P22 all encode at least two
lysis functions. One of the functions (lambda S , T4 t and P22
13) is thought to act on the inner cell membrane. Our results
suggest strongly that P22 13- protein and lambda S protein work
in the same way. The DNA sequences of S (Sanger et al. , 1982)
and 13 are 90 percent homologous. The amino acid sequences of
the protein products predicted by the DNA sequences are 89
percent homologous (see Fig. 4). These observations strongly
suggest that the proteins are virtually the same and would
likely be interchangeable. No sequence comparisons can be
made to T4 t since to our knowledge this gene has not yet been
sequenced.
The phages' second lysis function acts on the cell
wall. The lambda function is encoded by two genes , R and RZ.
The T4 and P22 genes are e and 19 respectively. P22 lysozyme
and T4 lysozyme have some amino acid sequence homology. This
homology is particularly interesting since it is localized to
regions of the protein near and in the active site of T4
lysozyme. The nature and implications of this homology are
discussed by Weaver et al. (1984). We have been unable to
detect any significant homology between P22 19 and lambda R or
RZ prote ins. This is not suprising since R is a
transglycosylase and RZ is an endopeptidase. It has been
shown previously that T4 lysozyme and lambda transglycosylase
differ in enzymatic activities as well as primary structure.
(Bienkowska-szewczyk and Taylor 1980; Black and Hogness, 1969;
Tsugita and Inouye, 1968).
complementation of Lysis defective phages. In infected
cells the products of T4 e, lambda R and RZ, and P22 19
require the activities of the membrane-disrupting proteins of
the respective phages in order to gain access to the cell
wall. We carried out an experiment to test the specificity of
this requirement. Plasmids were constructed that express
lambda R and RZ, P22 19 and T4 e. P22 and T4 functions were
expressed from plasmids that had similar structures, in which
the genes were placed downstream from the P promoter in a
pBR3 2 2 vector. The lambda genes were expressed from lambda
late ' A fragment of lambda DNA containing the carboxy
terminal region of gene Q, gene S, gene and gene RZ was
placed in a pBR322 vector. This plasmid was constructed using
DNA from an S-am phage. since the complementation tests were
done in Suppressor minus cells only genes R and RZ are
expressed. Expression from Plate requires the gene product of
Q or the homologous protein from P22, the gene product of 23
to be supplied in trans from the incoming P22 phage. Cells
bearing these plasmids were tested to see if they would
complement the growth defect of lambda R- or P22 19- The
results are given in Table All the plasmids complemented
both lambda R- and P22 19- We conclude from this that the
products of T4 e, lambda RZ and P22 19 are
interchangeable.
Discussion
Location and Sequence of the Lysis Genes We have
determined the sequences of P22 genes 13 and 19 , and thus
established their precise locations within a small segment of
the P22 chromosome. The lysis genes can also be mapped with
respect to other P22 sequences by comparison of the sequence
in Fig. 3 with that determined by Kroger and Hobom (personal
communication) . These investigators determined the DNA
sequence of a 5944 base pair segment of the P22 chromosome
extending from gene 18 to the start of gene 13, and
overlapping our sequence by 78 base pairs. The sequences
differ at one position. The base at position 77 is a c in our
sequence and a T in theirs, implying His and Tyr,
respectively, as the eighth amino acid residue in 13 protein.
These sequencing results, as well as other cloning and marker
rescue experiments (unpublished), lead to a map that differs
from that proposed by Rutila and Jackson (1981). These
authors reported that genes 13 and 19 map to the right of the
rightmost PstI site shown in Fig. 3, on the basis of marker
rescue experiments. We do not know the reason for this
discrepancy.
Mechanism of Action of Gene 13 Protein We nave
shown that P22 gene 13 protein is highly homologous to lambda
gene S protein. This finding in conjunction with previous
observations by others suggests that the proteins work in the
same way, by disrupting the inner cell membrane.
Speculation on the type of interactions that the
phage-encoded membrane-disrupting proteins have with their
respective lysozymes and with the inner cell membrane leads
one to two models. In one model membrane-disrupting proteins
attach to the inner cell membrane and then by a specific
interaction with the lysozyme allow the lysozyme access to the
cell wall. This could be a receptor-type interaction with
specific recognition taking place between the membrane-
disrupting protein and the lysozyme. In the extreme form of
this model, S protein would work only with R and RZ proteins
13 protein would work only with 19 protein, and t protein
would work only with e protein. We have shown this is not the
case. However, in a less extreme form one could postulate
that R, 19 and e proteins have in common some structures that
and 13 proteins recognize. These hypothetical common
structures are not reflected in any obvious way in the primary
structures of the proteins. A second model is that 13 and S
proteins act by forming pores or channels in the inner cell
membrane in a non-specific manner, creating an opening that
excludes only on the basis of size. Our results and those of
others (e.g. , Wilson, 1982) are fully consistent with this
view.
Mechanism of Action of gene 19 Protein. P22 gene 19
encodes a protein that lyses chloroform-treated E. coli cells.
This was shown by a number of observations. (1). Lytic
activity present in cells infected with P22 wild type is
missing or altered in cells infected with phage bearing
mutations in gene 19 (Botstein et al., 1972). (2). We have
purified a lytic activity from phage-infected cells and found
that the amino acid sequence of the principal protein species
present in the preparation is as predicted by the DNA sequence
of gene 19. (3). We have purified the same activity from
cells bearing plasmids containing P22 gene 19 and no other
intact phage genes (data not shown). This last observation
rules out the possibility that the lytic activity is the
product of any P22 gene other than 19.
Plasmids
pTP82
pTP163
pDR100
pDR101
pDR102
pDR103
pDR110
pDRl13
pDRl14
TABLE 1
PLASMIDS
HindII E fragment (Rutila and Jackson , 1981) of
P22 13-amH101 cl-7 inserted into the HindII site
of pTR262 (Roberts et al, 1980).
2000 bp gene 19 containing PstI fragment from
pTP82 inserted into the PstI site of pBR322.
1100 bp HpaI fragment containing gene 19 from
pTP163 ligated with BamH1 linkers , then
digested with BamHI , purified and ligated with
BamHI digested pBR322. The orientation is such
that gene 13 and 19 are transcribed in the
same direction as the bla gene of pBR3 2 2 .
1100 bp HpaI fragment containing gene 19 from
pTP163 ligated with BamH1 linkers , then
digested with BamHI purified and ligated with
BamHI digested pBR322. The orientation is such
that gene 13 and 19 are transcribed in the same
direction as the tetracycline resistance gene
of pBR322.
Deletion of DNA in pDR100
present in gene 19 to the
1284 in pBR322 , generated
NaeI and religation.
between the NaeI site
NaeI site at position
by digestion with
Deletion of DNA in pDR101 between the NaeI site
present in gene 19 to the NaeI site at 1284 in
pBR322 generated by digestion with NaeI and
religation.
A 189 bp MspI fragment containing an internal
coding region of gene 19 , derived from a 1100
bp HpaI fragment of P22 19-amHl162 cl-7
ligated into the ClaI site of pBR322.
A 423 bp MspI fragment containing an internal
coding region of of gene 19, derived from P2219-
amHl164 cl-7, ligated into the ClaI site of pBR322.
Same construction as pDRl13 except that the DNA
fragment was isolated from P22 19-amH1239 cl-7.
pDRl17 1100 bp HpaI fragment from P22 19-amH1026 cl-7
inserted into the EcoRV site of pBR322.
pDRl16 A 550 bp HincII-TaqI fragment from pDR100
ligated to an origin-containing fragment of
pBR322 generated by digestion with ClaI andPvII. The pDR100 fragment contains all of19. The ClaljTaqI junction reconstitutes a
site.
gene
ClaI
pDRl18 containing PstI-PvII fragment from P
rAmann et al , 1983) ligated with the lar
fragment generated by digestion of pDRl16 with
ClaI and PstI and filling in the ClaI end.
pDR105 This plasmid contains DNA from 3 sources. One
fragment is a HindIII-PstI fragment derived from a
pBR322 derivative which had the PvII site
converted to a HindIII site by the addition of a
HindIII linker. This fragment, which contains the
origin of pBR322, is joined to a HindIII-AvaII
fragment of T4 DNA from lambda-Ellle+ phage
(Owen et al, 1983) that contains gene e. The
AvaIl site is filled in and joined to a PstI-
vuII fragment from P 12 containing Pac 
pDR107 A 2298 bp fragment of lambda cl-857 S-am7 DNA
containing the 3' end of gene Q, gene S (S-
am7) , gene and gene RZ was generated by HindIII
and ClaI digestion. The ClaI site was filled in
and the fragment was ligated to an origin-
containing fragment of pBR322 generated byPvII and HindIII digestion.
TABLE
MAR RESCUE*
plasmid pTP163 pDR100 pDR102 pDR103
P22
19-amHl162 3x10-6 2x10-6 . 004
19-amH1026 lx10-6 6x10-6 . 001
19-arn111 2. 1x10-6 1x10-7 001
19-amH1239 1x10-7 1x10-7
19-amH447 4. 1x10-6 1.0 1.0 006 2. Ox10-6
* Figures shown are ratios of titers on MS1868 
(su ) bearing 
the indicated plasmids to titers on the permissive host MS1363 
(su 
The n+n symol means there was efficient plaque formation on
a spot test, not quantitated. Plasmid structures are depicted in Fig.
TABLE 3
COMPLEMENTATION*
Phage
Plasmid
Lambda S+ P22 P22
R-am 19-am13+ 13-am 19+
pDR105 (T4e)
pDRl18 (P2219)
pDR107 (lambda)
(R, RZ)
none
Complementation. * Plasmid bearing cells ther
DB7000 for the P22 infections or W3110 lacI L8 for the
lambda infections) were spotted with dilutions of the
indicated phage and lysis was noted. Plating efficiencies
were determined and in all + cases were found to be 1. 0 relative to
growth on Su+ cells (MS1363 or C600). ND indicates not done.
Fig. 1 structures of plasmids used for sequencing and
complementation. The top line shows location of P22 genes
The location of gene 23 is established by, 13 , and 19.
the sequence of Kroger and Hobom (personal communication).
Genes 13 and 19 are located as described in the text. The
next 4 lines show the regions of the P22 chromosome present
in each pBR322 derivative plasmid. The last three lines
diagram the plasmids used for complementation tests. The
arrows represent P 
tac promoters.
summarized in Table 
Plasmid construction is
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Fig. 2. DNA sequencing strategy. The bars indicate the
location of gene 13 and gene 19 coding sequence. The arrows
indicate the orgin and extent of sequence information
obtained from different fragments. The arrrows above the
map repreSent sequence determinations from labeled 5' ends;
the arrows below , from labeled 3 I ends. The enzymes used
were: EcoRII (E), HpaI (Hp) , FnudII (F), MspI (M), DdeI
(D), TaqI (T), HinfI (H), and NaeI (N).
ECb RIr
Msp
Dde.I
HinfI Msp Ta'fI
Hinfr
Msp
HinfI
Ta'tI
Fig. 3. DNA sequence and amino acid translation of gene 13
and gene 19 of P22. The amino acid translation of gene 13 is
shown above the nucleotide sequence and gene 19 translation
is shown below the nucleotide sequence. Numbers are shown to
the left of the corresponding base. The positions of
mutations sequenced are shown by a * above the base. The
alleles sequenced were 13- amH101 (C to T at position 113),
13-h21 (G to T at position 226), 19-amHl162 (C to T at
position 555), 19-amHl164 (ACC to CTT at positions 700, 701
and 702), 19-amH1239 (G to A at position 730); they are
shown in order.
Met Lys Lys Met Pro Gl 1 CCAATATCAACCAATTCATAACATTGAACAATCCTCACGGTCGTGAGGTAAGAC ATG 
AA AAG ATG CCA GAA
Lys His Asp Leu Leu Thr Ala Met Met Ala Ala Lys Glu Gln Gly lle Gly Ala lle Leu
74 AAA CAT GAT CTG TTA ACC GCC ATG ATG GCG GCA 
AAG GAA CAG GGC ATC GGG GCA ATC CTC
Ala Phe Ala Met Ala Tyr Leu Arg Gly Arg Tyr Asn Gly Gly Ala Phe Lys Lys Thr Leu
134 GCG TTT GCA ATG GCG TAC CTT CGC GGT CGG TAT AAT GGC GGT GCG TTT 
AAG AA ACA CTA
lle Asp Ala Thr Met Cys Ala lle lle Ala frp Phe lle Arg Asp Leu Leu Val Phe Ala
194 ATA GAC GCA ACG ATG TGC GCC ATT ATC GCC TGG TTC ATT CGT GAC CTT TTA GTC TTC GCC
Gly Leu Ser Ser Asn Leu Ala Tyr lle Ala Ser Val Phe lle Gly Tyr lle Gly Thr Asp
Z54 GGA CTG AGT AGC AAT CTT GCT TAC ATA GCG AGT GTG TTT ATC GGC TAC ATC GGC ACA GAC
Ser lle Gly Ser Leu lle Lys Arg Phe Ala Ala Lys Lys Ala G1y Val Asp Asp Ala Asn
314 TCG ATT GGT TCG CTA ATC AAA CGC TTC GCT GCT AM AA GCC GGA GTC GAT GAT GCA AAT
Met Met Gln 11e
G 1 n G1 n ***
372 CAG CAG TAA C GGA ATC ACC AGA TTA AM CGT GA GAA GGT GAG AGA CTA AA GCC TATSer Ser Asn G1y lle Thr Arg Leu Lys Arg G1u G1u G1y G1u Arg Leu Lys Ala Tyr
432 TCA GAT AGC AGG GGG ATA CCA ACC ATT GGG GTT GGG CAT ACC GGA AA GTG GAT GGT AATSer Asp Ser Arg G1y 11e Pro Thr lle G1y Val G1y His Thr G1y Lys Val Asp G1y Asn
492 TCT GTC GCA TCA GGG ATG ACA ATC ACC GCC GA AM TCT TCT GA CTG CTT AM GAG GATSer Val Ala Ser G1y Met Thr lle Thr Ala G1u Lys Ser Ser G1u Leu Leu Lys G1u Asp
552 TTG CAG TGG GTT GAA GAT GCG ATA AGT AGT CTT GTT CGC GTC CCG CTA AAT CAG AAC CAG
Leu Gln Trp Val Glu Asp Ala lle Ser Ser Leu Val Arg Val Pro Leu Asn Gln Asn Gln
612 TAT GAT GCG CTA TGT AGC CTG ATA TTC AAC ATA GGT 
AAA TCA GCA TTT GCC GGC TCT ACC
Tyr Asp Ala Leu Cys Ser Leu lle Phe Asn 11e G1y Lys Ser Ala Phe Ala Gly Ser Thr
672 GTT CTT CGC CAG TTG AAT TTA AAG AAT TAC tAG GCA GCA GCA GAT GCT TTC CTG TTA 
"TGGVal Leu Arg Gln Leu Asn Leu Lys Asn Tyr G1n Ala Ala Ala Asp Ala Phe Leu Leu Trp
732 AA AM GCT GGT AAA GAC CCT GAT ATT CTC CTT CCA CGG AGG CGG CGA GA 
AGA GCG CTGLys Lys Ala G1y Lys Asp Pro Asp 11 e Leu Leu Pro Arg Arg Arg Arg G1 u Arg Ala Leu
792 TTC TTA TCG TGA GTCGTATTAAGGCAATTATTGCGTCTGTCATTATCTGCATCATCGTCTGTCTTTCGTGGGCTG
Phe Leu Ser ***
867 TT AA TCA TT A TCGTGA T AACGCCA TCACCT ACAMGAGCAGCGCGA T AAGCCACA TCAA TCA TCGCTGA T A TGCAGA
946 GCGTCAACGAGA TGTAGCAGAACTCGA TGCCAGA T ACACAMGGGACTTGCTGA TGCT AACGCGACTA TCGAMCTCTC
1 025 CGCGCTGA TGTTTC TGCTGGCGT AAGCGCCTGCAAGTCTCCGCCACCTGTCCAAGTCAACGACCGGAGCCAGCGGCA T
1104 GGGCGA TGGAGAAAGCCCAAGACTTACAGCAGA TGCTGAACTCAA TT A TTACCGTCTCCGAAGTGGAA TCGACAGGA T A
1183 ACCGCG
Fi gure 3
Fig. 4. An Amino acid sequence (predicted from DNA sequence)
comparison between lambda S and P22 13. P22 13 is shown on
the top line and lambda S is given on the lower line. There
is 89 percent homology between the two proteins.
MET LYS LYS MET PRO GLU LYS HIS ASP LEU LEU THR ALA MET MET ALA ALA LYS GLU
MET L YS --- MET PRO GLU L YS H IS ASP LEU LEU ALA ALA ILE LEU ALA ALA L YS GLU
- -------- ----
GLN GL Y I LE GL Y ALA I LE LEU ALA PHE ALA MET ALA TYR LEU ARG GL Y ARG TYR ASN
GLN GL Y ILE GL Y ALA ILE LEU ALA PHE ALA MET ALA TYR LEU ARG GL Y ARG TYR ASN
- - ----
GLY GLY ALA PHE LYS LYS THR LEU ILE ASP ALA THR MET CYS ALA ILE ILE ALA TRP
GLY GLY ALA PHE THR LYS THR VAL ILE ASP ALA THR MET CYS ALA ILE ILE ALA TRP
  
PHE ILE ARG ASP LEU LEU VAL PHE ALA GLY LEU SER SER ASN LEU ALA TYR ILE ALA
PHE ILE ARG ASP LEU LEU ASP PHE ALA GL Y LEU SER SER ASN LEU ALA TYR ILE THR
----- 
SER VAL PHE I LE GL Y TYR I LE GL Y THR ASP SER I LE GL Y SER LEU I LE L YS ARG PHE
SER VAL PHE ILE GL Y TYR ILE GL Y THR ASP SER ILE GL Y SER LEU ILE L YS ARG PHE
ALA ALA L YS L YS ALA GL Y VAL ASP ASP ALA ASN GLH GLH
ALA ALA L YS L YS ALA GL Y VAL GLU ASP GL Y ARG ASH GLN
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CHAPTER III
ISOLATION AND CHACTERIZATION OF P22 LYSOZYME AMBER
MUTATIONS
Introduction
Studies described in the previous chapter resulted in
the identification of five different amber mutations in the
P22 lysozyme gene; three were sequenced and found to be at
codons 64, 113 , and 122. Subsequently the others were
sequenced and found to be at codons 65 and 80. To enlarge this
collection, seven more amber mutations were created at six
addi tional codons by mismatched primer-directed mutagenesis in
vitro. oligonucleotides that incorporated amber codons were
used as primers of DNA synthesis on single stranded plasmid
templates bearing gene 19. The amber mutations were
subsequently transferred to P22 by homologous recombination in
vivo. In this chapter I describe the procedures used to create
the amber mutations. The phage bearing the amber mutations in
gene 19 were plated on six suppressor strains to determine
which amino acid substitutions yielded functional lysozyme.
Materials and Methods
Enzymes, buffers and media. T4 DNA ligase, restriction
endonucleases, and E. coli DNA polymerase I large fragment
were purchased from New England Biolabs. AM reverse
transcriptase, HpaI restriction endonuclease, and Sal 
restriction endonuclease were purchased from Boehringer-
Mannheim. P22 tail protein was a gift from Peter Berget. Hen
egg white lysozyme (HEWL) was dissolved in water (1 mg/ml), it
was used at a final concentration of 20 to 50 g/ml.
Restriction buffers , kinase buffer , and ligase buffer
were as recommended by the suppliers. PCM was 10 mM Pipes pH
8, 10 mM caCl2' and 10 mM MgCl 10 x sample buffer was
25% bromophenol blue, 0. 25% xylene cyanol and 25% glycerol.
Sequencing gel loading buffer was 80% deionized formam ide , 50
mM Tris-borate (pH 8. 3), 1 mM EDTA , 0. 1% (w/v) xylene cyanol
and 0. 1% (w/v) bromophenol blue. Precipitation buffer was 20
mM Tris HCl pH 8. 0, 10 mM NaCl, 2 mM EDTA , and 0. 5 M NH Ac.
x AB buffer was 250 mM Tris HCl, pH 8. 300 mM NaCl , and 50
mM DTT. 5 x RT was 250 mM Tris HCl , pH 8. , 300 mM NaCl , 50
mM DTT, and 150 mM Mg (OAc) 2' 5 x dNTP was a mixture of all
four dNTP' s at 2 mM in 1 x AB. 5 x ddNTP was (one mixture for
each of the four ddNTP' s) each ddNTP at 250 mM in 1 x AB.
Buffer C was 200 mM Tris HCl pH 7. 6, 100 mM MgCl, 500 mM NaCl
and 10 mM DTT. Buffer D was 200 mM Tris HCl pH 7. 6, 100 mM
MgCl . DNA buffer was 10 mM Tris HCl (pH 7. 4), 5 mM NaCl , and.
1 mM EDTA. BS (buffered saline) was 90% (% vol) 0. 85% NaCl
and 10% SB. SB was 0. 4 M Na HPo4' and 1. 1 M KH 4 pH
approximately 7. 
LB broth contained 10 g tryptone, 5 g yeast extract, 5
g NaCl , and 1 ml 1 M NaOH per liter. LB agar contained , in
addition , 15 g agar per liter. LB medium was supplemented
wi th appropriate antibiotics at the following concentrations;
10 to 20 g tetracyclinejml , 50 to 100 g ampicillinjml, or 20
gjml kanamycin for growth of plasmid-bearing strains. Soft
agar contained 10 g tryptone, 2. 5 g NaCl and 9 g agar per
liter. Minimal medium was M9CAA (Smith and Levine , 1964) with
the casein hydrolysate omitted. M9 plus glucose was minimal
media with 1% glucose added. Lambda plates contained 10 g
tryptone, 2. 5 g NaCl and 11 g agar per liter of H
Plasmids. Plasmid constructions were done by standard
methods (Maniatis et al. , 1982). Transformation of Salmonella
was carried out as described by Lederberg and Cohen (1974).
Plasmids used for constructions are derivatives of
pBR322 (Bolivar et al., 1977). The details of the
constructions are given in Table 4. Plasmids pGFIB:phe and
pGFIB: cys (Normanly et al., 1986); pDR105 , pDRl18 , pDR110
pDR100, and pDRl16 (Rennell and Poteete, 1985 ;Table 1 and Fig
1); pTP352 (Knight et al., 1987); pTP30 (Berget et al. , 1983);
pZ152 (Zagursky and Berman , 1983); and pKM101 ampr (Youderian
et al. , 1982) were previously described. Plasmid pPB20:: Tn5-
13 was generously supplied to us by Peter Berget. This
plasmid has the pBR322 HindIII-BamHI origin of replication
fragment; a 4800 bp segment of bacteriophage T4 DNA containing
. all of gene 7, part of gene 6, and part of gene 8; and Tn5
inserted in the T4 DNA portion. Plasmids pDR281 and pDR392
were used for the site directed mutagenesis. Both plasmids
contain an M13 origin of replication and P22 gene 19. pDR281
confers ampicillin resistance and has gene 19 under P
control. Plasmid pDR392 confers tetracycline resistance and
has gene 19 under P control. pBR322 oc4 is pBR322
containing an ochre mutation in the 4th codon of beta
lactamase. This plasmid was generously supplied to us by
David Botstein. pDR321 was used to construct the defective
It contains a 5. 04 kilobase internal HpaIphage P22 Kn321.
fragment of Tn5 (Rothstein et al., 1980). obtained from
pPB20: : Tn5 -13, inserted into the middl e 0 f the coding sequence
of gene 19. This Tn5 DNA encodes resistance to kanamycin
(Jorgensen et 
., 
1979) and is unable to transpose because it
lacks essential parts of the transposon' s insertion sequences.
Plasmid pDR321 also has P22 DNA flanking gene 19 in order to
allow for homologous recombination between the phage and the
plasmid.
Plasmids pGFIB: phe and pGFIB: cys , encode amber
suppressor tRNA' s that insert phenylalanine and cysteine
respectively; both confer resistance to ampicillin as well
(Normanly et al., 1986). I found that Salmonella strains
bearing these plasmids were unstable, tending to lose the
plasmids during prolonged growth in liquid culture in spite of
the addition of ampicillin to the medium. To give the
plasmids a more strongly selectable trait they were modified
by the addition of the tetracycline resistance determinant of
pBR322 ( See Table 4 ).
Bacteria. Escherichia coli W3110 lacI L8 (Brent 
Ptashne, 1981) was used for propagation of plasmids and for
growth of lambda phage. W3110 (Lederberg, 1960) was used as
host to prophage P22 Kn321 sieA44 m44. strain GM1675 dam-4
del (lac-pro) thi-1 supE relA1 IF'lacI del (M15) pro+ used for
propagating phage f1 IR1 and generating single-strand
plasmids, was provided by Martin Marinus. All other strains
are derivatives of Salmonella typhimurium LT2. strains
MS1362 , MS1363 , MS1364 , MS1365 (all leuAam414 , bearing the
amber suppressor alleles supD, supE , supF, supG , respectively),
DB7000 (leuAam414), MS1868 (leuAam414 m+), MS2310 (MS1868
bearing the plasmid pKM101 amp ), and MS1387 supQ pro (del
attP22) cysB his leuD fol101 IF'lac pro were from Miriam
Susskind. strain CVl12 (polAts) (Van Beveran , Ph. D. thesis
Tufts University, 1985) was provided by Andrew Wright. TP278
TP279 , TP280 , TP282 are MS2310 with supE supF , supG, and supD
respectively. These strains were created by transducing with
P22 HT the amber-suppressors from MS1363, MS1364 , MS1365 and
MS1362 into MS2310 and selecting leu + transductants on minimal
medium containing ampicillin. TP284 is MS1868 lysogenized
TP292 and TP241 are W3110 andwith P22 sieA44 Ap2 del 7283.
MS1363 respectively, lysogenized with P22 Kn321 sieA44 m44.
TP308 and TP309 are MS2310 bearing pDR463 and pDR464
respectively. TP320 is MS1868 with plasmid pDR105.
Phage. Lambda phage Ram5 cI - was used for
complementation tests. Phage f1 IR1 (Enea and Zinder , 1982)
was used to package single stranded plasmids. The remainder
of the phages used were P22. synthetic amber mutations were
introduced into P22 sieA44 m44. P22 HT was used for
transductions. A lysogen of P22 Ap2 sieA44 mnt-ts1 (deletion
Ap2-gene 20) was used to titer defective oversized P22
particles (Weinstock et al. , 1979). The phage bearing amber
mutations in gene 19 were either clear derivatives that had a
plaque morphology marker (h21) as described in chapter 2 (P22
19- amHl162 h21 cl-7, P22 19-amHl164 h21 cl-7 P22 19-amH1239
J21 cl-7, P22 19-amN111 c2, and P22 19-amH1026 h21 cl-7) 
c+ phage as described in this chapter (P22 sieA44 m44 19am12,
P22 sieA44 m44 19am22, P22 sieA44 m44 19am39, P22 sieA44 m44
19am61, P22 sieA44 m44 19am65 , P22 sieA44 m44 19am82 , and P22
sieA44 m44 19am83). The five amber alleles described in
chapter 2 have been renamed to agree with the nomenclature
used for the rest of amber alleles . 19-amHl162, 19-amHl164,
19-amH1239, 19-amN111, and 19-amH1026 will be known as 19am64,
19aml13 , 19am122, 19am80, and 19am65 respectively. I will not
mention the sieA44 m44, h21, c2, or cl-7 alleles below when
describing the 19am phage. The phage used in immunity tests
were P22 vir3, P22 c2-5, and P22 cl-7. The defective P22 phage
used to cross mutant alleles of gene 19 from plasmids to phage
was P22 Kn321 sieA44 m44.
I had many problems with P22 19am122 (trp) . The
suppression pattern showed that it was ts with all the
suppressor strains. The ts phenotype was attributed to the
lysozyme gene, since phage plated on lysozyme-producing cells
at 40 C would yield a wild type plaque size indicating that
only lysozyme was defective at 40 C. The reversion rate of
this ts phenotype was such that in a typical stock there would
be 10% non-ts phage that still contained amber mutations.
These revertants did not yield wild type phage in a cross with
the 19am122 (trp) parent indicating that the original amber
mutation was retained. The 19am22 allele was "backcrossed"
into P22 by constructing a plasmid containing this allele and
then allowing the plasmid to undergo homologous recombination
with P22 Kn321. The recombinant phage that resulted did not
have the ts phenotype, but still contained 9am122 (trp). I
reasoned that the original isolate of this phage had a second
mutation that made the phage ts. This mutation was crossed
out when I backcrossed the amber mutation. The new non-ts
phage would not recombine to yield wild type with the original
phage , therefore both phage contained the same amber mutation
Construction of P22 Kn321 sieA44 m44. A defective P22
phage was constructed by crossing P22 sieA44 m44 with a
plasmid that carried a selectable marker (See Fig. 5). MS1868
was transformed with pDR321. The plasmid-bearing strain was
then infected with P22 sieA44m44 at a multiplicity of 10 and
aerated at 37 C for two hours. The culture was treated with
chloroform and the lysate was used to transduce kanamycin
resistance to a polA-ts Salmonella strain (CVl12). The
transduction was done by infecting, at a multiplicity of 10 , a
5 ml culture of the polA strain which was at a cell density of
1 x 10 /ml. After 20 minutes for adsorption of the phage, 0.
ml of the infected cells was spread on a plate that contained
20 g/ml kanamycin. Plates were incubated at 30 C and at
C. The plates that were grown at 30 C had about 100
colonies , and when tested, most of the colonies had both
kanamycin and ampicillin resistance. This indicated that in
these colonies the entire plasmid was present. There were at
least 10 fold fewer colonies on the plates that were grown at
C. The majority of colonies that were tested were kanamycin
resistant and ampicillin sensitive , indicating that the
plasmid was not present.
The kanamycin resistant , ampicillin sensitive colonies
were further characterized by testing for immunity to P22
infection and ability to yield plaque-forming phage. In the
immunity test, colonies were cross streaked against P22 cl-7
P22 vir-3, and P22 c2-5. These phages were suspended in BS
buffer and 0. 1 ml streaks containing 1 x 108 plaque-forming
units were placed on lambda plates. The colonies to be tested
were streaked over the phage so that the last phage to be
encountered would be P22 vir-3. The plates were incubated
overnight at 37 In this test, lysogens are sensitive to
P22 vir-3 and resistant to P22 cl-7 and c2-5. In the "yielder"
test the recombinant lysogen should not be able to release
plaque-forming phage upon induction for two reasons. First
the 5. 04 kb Tn5 insertion makes the phage genome oversized.
Therefore, no individual phage will have a complete genome or
have the terminal redundancy necessary for circularization.
(The recombinant phage is able to form a lysogen, however:
two or more phage infecting the same cell can recombine and
circularize. Second , the recombinant phage is unable to
produce lysozyme , since the cOding sequence of gene 19 has
been interrupted by the Tn5 insertion. The phage yielding test
was done by making a small patch of the candidate lysogen on a
lambda plate , then exposing the plate to an inducing dose of
UV light. A drop of soft agar containing a small inoculum of
TP278 was placed over the patch. The plate was incubated at
C for 12 hours. Colonies that failed to yield phage and
were immune to cl-7 and c2-5 were tested further. As a
control , I carried out "yielder" tests with colonies which
were resistant to both kanamycin and ampicillin as well as
immune. All these colonies yielded plaque-forming phage upon
induction. This observation suggests that these colonies
contained both intact plasmid and phage. This could occur . if
the cell had been infected with both a transducing particle
and a phage particle. The PolA-ts allele might be "leaky"
allowing some plasmid replication. Another interpretation of
this observation would be the presence of a co integrate of the
phage and plasmid that resolved upon induction.
Candidate lysogens were grown as liquid cultures (20
ml) in LB plus kanamycin to a density of 2 x 10 jml and
induced with 2. gjml mitomycin C. The induced cultures were
aerated at 37 C for 3 hours and then 0. 5 ml of chloroform and
o . 5 ml HEWL (1 mgjml) were added to lyse the cell s . When the
culture cleared, debris was removed by low-speed
centrifugation. The phage particles were pelleted by a high
speed spin at 27, 000 g for 90 min. and resuspended with 2 ml
of BS. This stock of defective phage was titered on TP284.
The incoming phage recombine with the resident defective
prophage , in this way overcoming the lack of terminal
repetition due to the large Tn5 insertion, and thus being able
to circularize (Weinstock et al., 1979). The resident prophage
has an intact lysozyme gene , and so can complement incoming
19- phage.
The P22 Kn321 stock was used to lysogenize MS1363.
kanamycin resistant colony was chosen and checked for the
presence of a defective prophage as described above. This
strain (TP241) was used to cross plasmid-borne amber
alleles onto the phage genome (see Fig. 6).
When I started developing these methods I used the
Salmonella strain TP241 , but found this to be cumbersome since
to transform this strain with the amber-bearing plasmid
plasmids had to be prepared by CsCl equilibrium gradients.
This was necessary since the efficiency of transformation of
Salmonella is at least 1000 fold lower than that of
Escherichia coli. Therefore, the defective prophage was moved
to an Escherichia coli strain by mating. The Escherichia coli
strain carrying the defective P22 prophage (TP292) was used in
the same manner as the Salmonella strain (TP241), except it
could be transformed with DNA isolated from minilysates. The
E. coli lysogen was made by A. Poteete. Briefly, the steps
were: lysogenization of an auxotrophic F' Salmonella strain
(MS1387, supQ pro (del attP22) cys his leuD fol101 /F'lac pro)
with P22 Kn321 , then mating this lysogen with an E. coli 
prototroph (W3110), and selecting a kanamycin resistant
prototroph.
Mutagenic primers. The primers were 15 base
oligonucleotides synthesized by the University of
Massachusetts DNA synthesis facility. They were designed to
introduce amber codons into P22 gene 19. The sequences of the
pr imers are:
am12 (lys)
am22 (tyr)
5 'AGATTA AQCGTGAA 3'
5 'GCCTAQTCAGATAGC 3'
am39 (val)
am61 (glu)
5 'GGAATAGGATGGT 3'
5 'CTGCTTAA AGGAT 3'
am65 (trp)
am82 (gln)
5 'TTGCAGTAGGTTGAA 3'
5 'CTAAT AGTATGAT 3'
am83 (tyr) 5 'AACCAGTA GATGCG 3'
The mismatched bases were at least 5 bases in from the 
end. The primers were supplied as lyophilized mixtures of the
15-mer and all the products of incomplete incorporation. This
mixture was resuspended with 1 ml of water which normally
yielded a solution of 4mg/ml. The primers were phosphorylated.
The kinase reaction mixture contained:
75 l of the primer mixture (about 300 ug)
15 l 10 x kinase buffer
20 l ATP (100 mM)
l T4 DNA kinase
38 l of H
The mixture was incubated at 37 C for 30 minutes.
Oligonucleotides were then repurified by phenol extraction and
ethanol precipitation. The pellet was resuspended with 7 
DNA buffer. The DNA was then electrophoresed after the
addition of 7. l sample buffer, at 150 volts on a 20%
acrylamide , 1% bis-acrylamide gel until the bromophenol blue
migrated 17 centimeters. To visualize the DNA, the gel plates
were separated and the plate with the gel was placed over a
sheet of Kodak Eastman "chromogram sheet" (a thin layer of
cellulose with a fluorescent indicator) and then illuminated
from above with a short wave UV light. The DNA created
visible shadows. The 15-mer was easily distinguished from the
other bands which formed a ladder from 1-mers to 14 -mers . The
15-mer band was cut out of the gel by using a razor blade. The
gel slice was finely diced with a razor blade and placed in 1
ml of 0. 5 M ammonium acetate , 1 mM EDTA. This was incubated
with shaking at 37 C for 12 hours. The solution was then spun
by low speed centrifugation through a large (1 ml) pipet tip
and the eluate collected in a plastic 3ml vial. The pipet tip
trapped the gel fragments. The fragments were then washed
twice with 200 l of the ammonium acetate solution. The
resultant 1. 4 ml was brought up to a volume of 10 ml with H
and further purified on a "Sep-Pak" C
18 cartridge (Waters).
The Sep-Pak column was prepared by washing with 10 ml of
ethanol, then 10 ml of 10 mM ammonium acetate
, followed by 10
ml of H The sample was applied to the column and pushed
gently through. The column was washed with 10 ml of 10 mM
ammonium acetate and the DNA was eluted with 25% ethanol
, 75%
30 mM ammonium acetate. Most of the 15-mer eluted in the
first 1 ml, but 1. 5 ml was routinely collected. This
suspension was frozen and lyophilized. The powder was
resuspended with O. 5 ml of DNA buffer. The absorbance at 260
nm was determined and the concentration of DNA was estimated
assuming that the A2 60 of 2 g ol igonucleotide/ml is 1. 0 .
Isolation of single strand template. GM1675 was
transformed to ampicillin resistance with pDR281. GM1675 was
used since it has a mutation in dam; plasmid or phage grown in
this strain are not methylated at dam sites (GATC). When single
strand plasmid isolated from this strain is used as template
for in vitro second strand synthesis , both strands of the
resul ting duplex are unmethylated at dam sites. When
unmethylated plasmid DNA is introduced into E. coli the
cell' s mismatch repair system will repair any mismatches
randomly, rather than repairing the newly synthesized
unmethylated strand preferentially as it. would if methylated
single stranded plasmid DNA was used as template. (Radman and
Wagner, 1984).
An individual transformant was streaked for single
colonies on an LB plate containing ampicillin. After overnight
incubation at 37 , a single colony was used to inoculate 5 ml
of LB broth (containing ampicillin) and the culture was grown
to saturation. A 0. 1 ml portion of the saturated culture was
used to inoculate 2 ml of LB broth that contained 100 g/ml
ampicillin. 1 x 10 11 f1 IR1 phage were added. The culture was
aerated at 37 C for five to eight hours. The cells were
pelleted by spinning 1. 5 ml in the microfuge for 5 minutes.
The supernatant was added to 0. 15 ml of 20% PEG 2 M NaCl , and
incubated on ice for 15 minutes. The precipitated phage were
pelleted by a 10 minute spin in the microfuge. The
supernatant was poured off and the tube was wiped clean. The
pellet was resuspended with 0. 2 ml of DNA buffer and extracted
with an equal volume of phenol. Two drops of 8 M ammonium
acetate were added to the aqueous phase and the solution was
extracted with 0. 5 ml of ether. The tube was filled with
ethanol and placed at -70 C for 30 minutes and the DNA was
pelleted by spinning in a microfuge for 10 minutes. The
pellet was dried under vacuum and then resuspended with 20 
of DNA buffer.
The ratio of single strand phage DNA to single strand
plasmid DNA was estimated by visualizing the DNA after
electrophoresing 2 l on a 0. 7 percent agarose gel and
staining with ethidium bromide. The phage is 6 kb and the
plasmid is 4. 5 kb. The ratio of plasmid to phage DNA varied
between 1 and 0. 01.
The reason for the large variation in the amount of
plasmid DNA recovered has not been elucidated. Some possible
reasons were investigated. One possibility was the state of
the cells at the time of infection. However , varying the
procedure by infecting cells in early, mid, and late log phase
produced no consistent variation in the ratio of plasmid to
phage DNA recovered. Another possibility was the length of
time of infection. I varied the length of infection from 4
hours to overnight but again there was no consistent change in
the ratio recovered. It was noted that infections done for 6
hours seemed to yield the most total DNA. Another possibility
was that the culture lost the plasmid at a high frequency,
since the plasmid was detrimental to the cells: it has the
lysozyme gene under control of P . To investigate whether
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this was the problem, pDR392 was constructed because this has
the less active promoter Plac ; in addition , pDR392 confers
tetracycline resistance. This was tried because when
ampicillin resistant cells are grown in liquid culture , the
secreted -lactamase breaks down the ampicillin in the medium,
thus decreasing the drug concentration and thereby allowing
nonresistant cells to grow. Tetracycline resistance , on the
other hand , is mediated by activation of a membrane pump that
actively transports tetracycline out of the cells; the level
of drug in the medium remains constant, and a strong selection
for plasmid-bearing cells is maintained (Benveniste and Davis
1973). The plasmid conferring tetracycline resistance did not
change the variability of the ratio of phage to plasmid DNA
seen previously using the plasmid encoding ampicillin
resistance.
The only factor, that was found to affect the ratio of
phage to plasmid DNA recovered, was the length of time that
the plasmid had been resident in the cells at the time of
infection. The best procedure appeared to be to transform the
host cell with purified plasmid DNA, and to select
trans formants , grow liquid cultures , and infect in quick
succession, never allowing the plasmid-bearing cells to
experience less-than rapid growth for any significant period
of time. Adherence to this schedule typically resulted in
ratios between O. 5 and 1.
In vitro extension and ligation reactions. In vitro
extension-ligation reactions were done by mixing 0. 6 to 1 pmol
of single strand target plasmid (1 l of template prepared as 
described above) with 15 to 17 pmol of mutagenic primer (15
base oligonucleotide), 10 pmol of a primer designed to anneal
to pBR322 sequence in the plasmid such that it. s 3' end is 13
bases 5' of the EcoRI site (5' GTATCACGAGGCCCT 3' purchased
from New England Biolabs), 1 l of buffer C , and 5 l of H
This was incubated at 65 C for 5 minutes , then placed at room
temperature for 30 minu _es. To this annealing reaction , I
added 10 l of an enzyme mixture which contained 1 l 10 X
buffer D , l l of dNTP (2. 5 ro each of dATP , dGTP , dTTP, dCTP) 
l 100 ro ATP , 1 l 100 ro DTT , 2 (20 units) Escherichia
coli DNA polymerase I large fragment and 2 l of T4 DNA
ligase. The mixture was incubated at 15 C overnight. Control
reactions contained everything except for the mutagenic
pr imer .
I used three variations of this protocol to construct
the amber alleles. The variations consisted of different
single strand templates. The templates were derived from
pDR281, pDR292, or pDR401. The use of the different
templates did not result in a change in the frequency of
obtaining amber mutations which was usually between 2 and 14%.
The plasmid pDR401 was used for the gapped circle
mutagenesis (Fig. 7) . The DNA species in the reaction
consisted of 0. 015 pmol of pDR401 which had been digested with
PstI, 1 pmol of a BamHI to EcoRI pBR322 origin- containing
fragment , and 10 pmol of the mutagenic primer (This reaction
should have had 1 pmol of each pDR401 and the BamHI-EcoRI
fragment) . Plasmid pDR401 is pBR322 oc4 with a fragment
containing a P promoter transcribing gene 19 inserted into
the EcoRI site. The plasmid is tet , amp , and lysozyre+ when
it is grown on a non ochre-suppressing strain. The double
strand DNA in the reaction was denatured by heating to 100
for 3 minutes then the mutagenic primer was added and the
reaction was heated at 65 C for 10 minutes. The DNAs were
then annealed by allowing the tube to set at room temperature
for 20 minutes at which time the Escherichia coli DNA
polymerase I large fragment and T4 DNA ligase were added.
This re ction was designed to increase the efficiency
of obtaining the mutant (See Fig. 7). The idea was to
decrease the amount of second strand synthesis that would be
needed to form a double strand plasmid. This reaction was also
designed to increase the chance of E. coli mismatch repair
system correcting the heteroduplex in such a way as to
conserve the amber mutation. The host for pDR401 was G 1675
(Dam-
), 
so that the newly formed heteroduplex would be
unmethylated at dam sites on the strand that contained the
ochre mutation and the lysozyme-plus allele , whereas the other
strand would be at least 3/4 methylated at these sites since
the pBR322 that the BamHI-EcoRI fragment was isolated from
was grown in a dam+ cell. The chances of maintaining the
lysozyme amber allele (introduced by the primer) and the
ampicillin resistance wild type allele (introduced on the
pBR322 fragment) would therefore be increased.
Only two products of the in vitro reaction would
plate on tetracycline and ampicillin plates, both which would
be a result of correction in the heteroduplex formed. One
would be the result of correcting the ochre in the beta-
lactamase gene but leaving intact the lysozyme gene either
because he mutagenic primer did not anneal or because the
mismatch repair system corrected the amber. The second product
that would plate was the product desired , a plasmid with a
wild type beta-lactamase and an amber in lysozyme gene. The
parents (the pBR322 fragment and the pDR401) were tetS or
amp . The reaction conditions were the same as outlined above,
except that the extension ligation reaction was done for only
2 hours.
screening for lysozyme mutants. The reaction mixtures
were used to transform W3110 lacI to ampicillin resistance.
The transformations were done by adding 1 to 2 l of reaction
mixture and 200 l of PCM to 300 l of competent E. coli
incubating at O c for 30 minutes , then at 37 C for 2 minutes
then at room temperature for 10 minutes. The transformation
mixtures were added to 2 ml LB broth and aerated at 37 C for
30 minutes , following which 0. 5 ml was spread on a LB
ampicillin plate. I normally obtained between 50 and 100
transformants per plate. On the control plates (no mutagenic
primer) I usually had about the same number of transformants.
Ampicillin resistant colonies that arose from the
transformation were screened for the introduced amber mutation
by a complementation test. Approx1ma e y 1 x 10 , 1 x 10 
and 1 x 10 4 plaque forming units of lambda cI-Ram were
streaked in lines on a lambda plate and the transformants were
streaked across the lines from the least dilute to the most
concentrated using a toothpick. The transformants that failed
to lyse contained plasmids that were defective in lysozyme
possibly because an amber mutation had been introduced. The
colonies from the control plates (no mutagenic primer added)
would consistently lyse indicating that the lysozyme gene was
intact. The percentage of experimental colonies that lysed
varied, depending upon the efficiency of the extension
ligation reaction. The range normally seen was between 1 and
40% . This did not seem to be a function of an individual
primer, since for any given primer the range would vary
between different reactions. Occasionally a colony would give
an intermediate result. If the positive control streak 
colony known to produce lysozyme) showed lysis when streaked
across 1 x 104 phage and a negative control colony (a colony
containing pBR322) had no lysis even when streaked across 1 x
8 phage, then an intermediate colony would show lysis when
streaked across 1 x 106 and possibly a small amount of lysis
when streaked across 1 x 10 phage. I reasoned that these
colonies arose because they contained two populations of
plasmids. One possibility was that the heteroduplex plasmid
that resulted from the in vitro reaction. was replicated before
it was corrected by the mismatch repair system. To determine
if this was the case, I streaked such an intermediate colony
for single colonies , then picked several single colonies and
streaked those for single colonies then tested several of the
single colonies. Three distinct populations of ampicillin
resistant colonies resulted: intermediate , lysozyme plus , and
lysozyme minus. This result showed that the cells did contain
more than one type of plasmid. Normally I discarded the
intermediate colonies because it was too time consuming to get
the plasmids to segregate.
Crossing amer alleles into P22. Plasmid DNA (isolated
from colonies that were scored as lysozyme minus), prepared by
CsCl equilibrium gradients or from minilysates , was used to
transform strain TP241 or strain TP292 to ampicillin
resistance (See Fig. 6). CsCl-purified plasmid DNA was used
to transform TP241, whereas DNA isolated from minilysates was
used to transform TP292. Transformed clones were purified by
streaking. Single colonies were used to inoculate 5 ml of LB
containing both ampicillin and kanamycin. The cultures were
grown with aeration at 37 C until they had reached a cell
density of about 2 x 10 /ml. Mitomycin C (2. 4 g/ml) was added
and the cultures were aerated for an additional 4 hours.
Chloroform (0. 5 ml) and HEWL were added to lyse the cultures.
The debris was spun out by a 5 minute spin at 5900 g and the
resul ting lysate was used to infect a Salmonella su+ strain.
Before the lysate was used for infection, the phage were
tailed by adding 1 x 1011 P22 tails. It has been noted that
induced P22 prophages are deficient in tails. I f the
Escherichia coli defective lysogen was used , then the
Salmonella su+ strain was also r- m+ so that unmodified phage
would not be restricted.
The Salmonella su+ strain used for the infection
depended upon which amino acid was originally encoded by the
codon that was changed to an amber. If the amber mutation
substituted for a codon of an amino acid for which a
suppressor tRNA strain was available, then that strain was
used since functional lysozyme would be produced. On the
other hand, if the amber mutation was in a codon that
previously specified an amino acid for which no suppressor
tRNA was available, then the lysate was used to infect all the
su+ strains.
The mitomycin c-induced lysates from TP292 or TP241
transformed with plasmids bearing amber mutations in gene 19
contain several different types of phage: (1) defective,
oversized, lysozyme minus phage (2) defective , lysozyme minus
phage that are no longer oversized because they have undergone
a deletion either of the inserted Tn5 DNA or a deletion of
part of the P22 genome, (3) 19 amber phage (See Fig. 6), and
( 4) wild type phage. Type 1 are induced P22 Kn3 21 with no
changes. Type 2 are no longer oversized because of a
spontaneous deletion of either Tn5 or P22 DNA, but they are
lysozyme minus due to the interruption of the coding sequence
of gene 19. Even if Tn5 DNA was deleted, there would still be
linker sequences present that would prevent lysozyme from
being produced since the correct reading frame would not be
restored. Type 2 could also be phage that still contain the
Tn5 DNA but have deleted at least 2 kb of phage genome so that
they are no longer oversized. Type 3 are phage that have
undergone homologous recombination with the plasmid such that
the amber mutation was crossed onto the phage. These phage
will plate if grown on a suppressor strain that inserts an
amino acid that is compatible at the position of the amber; or
if they are plated on a strain that provides a source of
lysozyme. Type 4 are phage that have undergone homologous
recombination with the plasmid at a point such that the amber
mutation was not crossed onto the phage genome. These phage
will plate on su- strains.
When the lysates were plated on suppressor plus
strains the selection for the recombinant phage is a double
selection based on the lysozyme-plus phenotype and upon the
ability of the phage to form a plaque upon single infection.
In cases where a source of lysozyme would be supplied 
(if none
of the available suppressors yield functional lysozyme), the
ability to form a plaque upon single infection would still
effect, since the phage would still be oversized and thus
unable to form a plaque upon single infection. In this
manner, the rare recombinant phage present in the induced
lysate was easily found. In most cases if 100 l of a 200 fold
dilution of the induced lysate was plated on a 
su+ strain,
about 50 plaques were formed. All of these plaques represented
recombinant phage. To determine if a recombinant contained an
amber mutation, the phage was plated on 
su- cells by
transferring phage from the plaque on the 
su+ lawn to a fresh
lawn of su- cells using a sterile toothpick. Those phage that
failed to grow were considered presumptive recombinant phage
that had acquired the plasmid-borne 19-amber mutation.
Normally about half of the recombinant phage contained amber
mutations. When 100 l of 200 fold dilution of induced lysate
was plated on TP284 (the strain used to titer the defective
particles), there was confluent lysis since all the defective
phage could now plate.
The phage bearing amber mutations were plaque purified
. .
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by taking a plug of agar containing the phage from the su+
strain and resuspending it in 1 ml BS with a drop of
chloroform. A 0. 1 ml portion of a 10-4 dilution of this
single-plaque lysate was plated on a permissive su+ strain.
An individual plaque was picked, and the single-plaque lysate
was used to streak for a single plaque on su+ permissive
cells. The single plaque was used to infect 30 ml of LB broth
that had been inoculated with 1 ml of saturated culture of a
permissive su+ strain. This stock culture was incubated at
C for 24 hours with aeration. Chloroform (0. 5 ml) was
added and the culture was further shaken for 20 minutes. The
cells and debris were then pelleted by centrifugation for 5
minutes at 5900 The resulting lysate was spun at 27 000 g
for 90 minutes to pellet the phage. The pellet was
resuspended with 2 ml of BS.
su+ permissive cells at 30
The phage stock was titered on
If there were any variations in
the plaques, such as smaller or pinpoint plaques among the
rest, the stock would be titered on the lysozyme producing
strain (TP320). In this way, I could tell if the su+ strain I
was using for my permissive strain was yielding an EOP of 
This was necessary since some of the amber mutations were not
at codons for which we had suppressor strains. By supplying
lysozyme from a plasmid, and thereby complementing the phage
in trans, it was possible to determine the actual titer.
TP320 could be used to plate phage which had an amber
mutation which resulted in nonfunctional lysozyme when plated
on any of the suppressors. The plasmid present in this
strain, pDR105 , produces T4 lysozyme from the P 
tac promoter.
This plasmid has virtually no homology at the DNA level with
P22 , therefore homologous recombination between the plasmid
and the phage is nil. This plasmid allows a lysozyme-defective
P22 to plate with an efficiency of 
I did not have any phage bearing amber mutations which
failed to grow on all the suppressor strains
, but I tried
using TP320 to see how it would work if I did need it.
theory TP320 should work fine but in practice I had an
unexpected difficulty. TP3 2 0 when infected with P22 results
in a high transduction frequency of the resident plasmid
(pDR105) . This transduction frequency of the plasmid is as
high as one normally sees when P22 infects a strain bearing a
plasmid that has known homology to the phage. There is no
significant homology that we know about between P22 and
pDR105. This transduction of pDR105 produces misleading
resul ts when screening phage that arise from an infection of
TP320. For instance , I plated an induced lysate
, from TP241
bearing the plasmid that carried am12
, on TP320.
were screened by stabbing into DB7000 and TP320.
The plaques
Phage that
were able to grow on TP320 but not on DB7000 were candidates
for recombinant phage bearing the amber mutation.
There were
4 phage out of 32 tested
, that failed to grow on DB7000.
These phage were then stabbed from TP320 into DB7000, TP320
and MS1363. The surprising result was that now only 1 of
these 4 phage failed to grow on DB7000. By passaging through
TP320 for a second time , three phage acquired the ability to
grow on DB7000. To test the possibility that transduction of
pDR105 was responsible I prepared single plaque lysates from
the DB7000 plate. These lysates were then used to infect
DB7000 and infected cells were spread on ampicillin plates.
There was a high percentage of transduction of the pDR105 amp
plasmid. This meant that by growing phage on TP3 , I was
obscuring my results.
Construction of Seven Amer Mutations. The alleles
am12, am65 , and am82 were made using single strand pDR392 as
the template strand. The transformation of W3110 lacl with
the am12 reaction yielded approximately 100 colonies. These
were screened for the ability to complement lambda cI- Ram. Of
the 100 colonies screened, 2 failed to complement. Those
clones were streaked and single colonies were isolated. DNA
was recovered from minilysates that were prepared from 5 ml
overnight cultures grown in LB plus ampicillin. This DNA was
used to transform TP241 to ampicillin resistance.
ampicillin/kanamycin resistant colony was used to inoculate 5
ml of LB plus ampicillin and kanamycin. A 0. 5 ml portion of
these overnight cultures was used to inoculate 50 ml of LB.
This was grown at 37 C until a cell density of 2 x 10 /ml was
attained , then 0. 4 ml of 0. 4 mgjml solution of mitomycin C was
added and the incubation was continued overnight. Chloroform
and HEWL was added and the debris was then spun out. The
resulting lysate was used to infect TP320. The plaques that
arose were plated on TP320 and DB7000 to distinguish the phage
which contained amber mutations. I found 1 plaque out of 50
that would grow on TP320 and MS1363 and not on DB7000. The
plaque on the MS1363 plate was used to make a single plaque
lysate. The phage was plaque purified and a stock was grown
on MS1363.
Amer 65 (tryptophan) was made by site directed
mutagenesis and also by hydroxylamine mutagenesis. I till
describe the amber mutation made by site directed mutagenesis
since this is the allele that I worked with the most (I did
not realize until after this allele had been created that one
of the chemically induced amber mutations in the collection had
the same change, because these amber mutations were not
sequenced until I was far along in the site directed
mutagenesis part of the project). I chose to work with the
site directed mutant , since it was less likely to contain
other extragenic mutations and because the phage was isogenic
with the rest of my collection.
The transformation of W3110 lacIQ with the extension
ligation reaction for am65 yielded approximately 100
ampicillin resistant colonies. Of these colonies , 2 failed to
complement lambda cI-Ram phage. DNA was prepared from
minilysates and was used to transform TP241 to ampicillin
resistance. A colony was chosen and used to grow a culture
which was induced with mitomycin C and lysed with chloroform
and HEWL. The lysate was supplemented with tail proteins and
used to infect MS1363 The resulting plaques were screened
by plating on DB7000. Of 12 plaques
, 3 were phage bearing
amber mutations. The phage bearing the amber mutations were
plaque purified and a stock was grown on MS1363.
After the mutagenesis reaction for am82 (glutamine),
W3110 laclq was transformed to ampicillin resistance. The
resul ting colonies were screened for the ability to complement
lambda cI-Ram. Of 100 colonies
, 3 failed to complement. DNA
was isolated and used to transform TP241 to ampicillin
resistance. A colony was selected This was grown at 37
until a cell density of 2 x 10 was attained , then mitomycin C
was added and the culture continued to aerate for 3 hours.
The lysate was recovered after a 15 min. incubation with
chloroform and HEWL. This lysate was used to infect MS1363.
The resulting plaques were screened for the amber mutation by
plating on DB7000. Of 13 plaques
, 2 contained amber mutations.
They were plaque purified and stocks were grown on MS1363.
Amers 22 (tyrosine), 61 (glutamate), and 83
(tyrosine) were created using single strand pDR281 as
template. Of 48 ampicillin resistant colonies from the am22
reaction, 3 were lysozyme-defective. There were 7 ampicillin
resistant colonies from the am61 reaction and 1 was lysozyme-
defective. Of the 22 colonies tested from the am83 reaction
, 1
was lysozyme-defective. Plasmid DNA was prepared from each of
these colonies. A 10 l sample of plasmid DNA was used to
transform TP241. Ampicillin resistant colonies were selected
and grown in 50 ml of LB with ampicillin and kanamycin
, then
induced for four hours with mitomycin After addition of
chloroform and HEWL, the lysates were cleared of debris and
used to infect suppressor strains. The infections were done
using 100 l of the induced lysates and 0. 3 ml of cells which
were at a density of 3x10 /ml. AS1364 was used for am22 and
am83 while MS1363 was used for am61. The resulting plaques
were screened to see if they would plate on DB7000. Of the 49
plaques tested from the lysate of am22 , 3 were contained amber
mutations. Of the 49 plaques tested from the lysate of am61
28 were phage that had amber mutations. The 19am83 (tyr)
lysate yielded 42 plaques and 33 of these were phage with
amber mutations.
The amber 39 (valine) mutation was created by using a
gapped heteroduplex for template as previously. The in vitro
reaction mixture was used to transform W3110 and ampicillin
resistant colonies were screened for ability to complement
lambda 1 of the 80 colonies tested failed to complement.
This colony was streaked for singles and the singles were
retested for noncomplementing activity. They all tested
lysozyme-defective. A single colony was used to grow a 5 ml
culture and DNA was prepared from a minilysate.
The DNA was used to transform TP292, the E. coli
strain bearing P22 Kn321 , to ampr and tet A resistant
colony was selected and streaked for singles. A single colony
was used to inoculate 50 ml of LB plus ampicillin and
tetracycline. This culture was grown to a density of 2 x
/ml and induced with mitomycin C for four hours at 37
Chloroform and HEWL were added and the debris was spun out.
The lysate was used to infect TP278. The resultant plaques
were plated on MS1362, MS1363, and DB7000. Of the 14 plaques
tested, 6 were phage that had incorportated amber mutations.
One of these mutant phages was selected and a phage stock was
grown on MS1363.
sequencing the phage bearing amer mutations. DNA was
extracted from 0. 4 ml of phage stock in a microfuge tube by
adding 2 l diethylpyrocarbonate, 10 l 10% SDS and 50 l 2 M
Tris-HCl O. 2M Na EDTA (pH 8. 5), and incubating uncovered at
C in a fume hood for 5 minutes. Protein and SDS were
precipitated by addition of 50 l 5 M potassium acetate
followed by incubation on ice for 30 min , and centrifugation
in a microfuge for 10 minutes. The supernatant was
transferred to a new tube, and the DNA was precipitated with
5 volumes of ethanol. The DNA was spun onto a sealed glass
pasteur pipet and transferred to a clean microfuge tube
containing 2 00 l precipitation buffer. The tip of the pipet
was washed with the buffer repeatedly, until all the DNA went
into solution. Following extraction with 3 drops of phenol,
the aqueous phase was removed and extracted with 1 ml ether.
The ether phase was removed , and the DNA was precipitated with
5 volumes of ethanol , pelleted by centrifugation in a
microfuge , dried under vacuum, and redissolved with 50 l DNA
buffer (It does not go into solution quickly; drawing it
repeatedly into a pipetman tip helps). The usual yield from
this procedure tt dS about 50 ug DNA.
The phage DNA was digested with HindIII (25 l in 50 
with 20 units HindIII) overnight at 37 C. The digestion was
checked by running 2 l in an agarose gel. The crudely
purified DNA occasionally resists cutting. In these cases
complete digestion can usually be achieved by phenol and ether
extraction of the reaction mixture , followed by precipitation
washing and drying as described above, and repetition of the
digestion reaction. The reaction mixture can be used directly
in the sequencing reactions.
The sequencing primers were purified in the same
manner as the mutagenic primers, except the sequencing primers
were not kinased before purification. The primers used were:
( 1) 5' CTCGATTGGTTCGCT 
(2) 5' GTTGGGCATACCGGA 
(3) 5 I AGTAGTCTTGTTCGC 3 
( 4 ) 5 I GCTTTCCTGTTATGG 3 I
After gel electrophoresis, elution from the Sep-Pak
column , and lyophilization, the DNA was dissolved with 1 ml of
DNA buffer and the absorbance at 260 nm was determined. The
primers were phosphorylated in a reaction mixture that
contained:
l primer at 10 pmolj
l DNA buffer
l 10 x kinase buffer
gamma- -ATP (3000 Cijmmol, 10 mCijml)
l T4 polynucleotide kinase ( NEB 8 Uj
The reaction was carried out at 37 C for 45 min, then stopped
by incubation at 90 C for 3 min. 40 l DNA buffer was added
the reaction was phenol extracted , followed by ether
extraction, and then the ether was boiled off at 90 This
preparation was used directly for sequencing.
usable for at least two weeks at -20
It remains
The annealing and primer extension reaction mixture
contained:
l kinased primer (0. 6 pmol)
l HindllI-digested P22 DNA ( 0. 04 pmol)
2 . 4 l 5 x AB
4. 6 l water
This mixture was placed in a microfuge tube and spun
in a microfuge for 2 seconds. This was incubated at 90 C for
3 min. , spun to collect in the bottom of the tube , frozen with
dry ice , then thawed on wet ice. l portions of the
anneal ing mixture were added to tubes labeled G, A, T, and C
each containing 1 l dNTP mix, 1 l the appropriate ddNTP , and
l RT mix. These were spun to collect the liquid at the
bottom of the tubes , then incubated at 50 C for 15 min., spun
again, then 1 l more RT mix was added. Incubation continued
for an additional 15 min. at 50 C. The tubes were spun again
and the reaction was stopped by adding 5 1 sequencing dye
buffer and heating to 90 C for 3 min.. After another spin the
tubes were placed on ice and 2 l samples were loaded on a
sequencing gel. Sequences were usually readable after a 24
hr. exposure of the dried-down gel to film at -80 C. 
intensifying screen was used.
The 19am phage were sequenced to confirm the presence
of the presumed amber mutation. Three 19am phage were
sequenced by using the chemical modification sequencing
protocol of Maxam and Gilbert. These phage; am64 , aml13 , and
am122 were described in the previous chapter. The rest of the
19am phage were sequenced using the dideoxy chain termination
protocol.
Phage 19 am61, am65 , am81 , am82 , and am83 were
sequenced using primer #2. The codons sequenced were 40
through 102. Phage 19 am12 , am22 , and am39 were sequenced
using primer # The sequenced DNA represented codons 99 of
gene 13 through codon 50 of gene 19. In all cases the amber
j;.
mutation was confirmed and no other changes were present. The
gene 19 alelle am65 was created twice, once by hydroxylamine
mutagenesis and once by site directed mutagenesis.
Recombination tests. Recombination experiments were
performed between alleles of P22 19am phage to determine if
mutations were in the same nucleotide or neighboring
nucleotides. The experiments were done by spotting 10 l of
BS containing 1 x 10 phage onto a freshly. poured bacterial
lawn. The bacterial lawn consisted of an LB plate with 2. 5 ml
of soft agar and 0. 5 ml of a culture of TP266 at a density of
2 x 10 . The spot was allowed to dry at room temperature for 5
minutes and then the second phage was spotted directly over
the dried spot. The second phage spot was allowed to dry and
the plate was incubated at 37 C overnight. If the phage
tested had mutations that were wi thin 3 to 6 bases of the
original mutation then the spot would not show signs of lysis.
On the other hand if the phage had mutations that were
separated by at least 6 bases then recombinant phage would
lyse the spot on the bacterial lawn. Negative control spots
were parental self-crosses done using 20 
l of the phage
suspensions. positive control spots were done using phage that
were known to contain mutations that were separated by at
least 6 bases.
Determining suppression Patterns. 
Suppression patterns
were determined for 19am phage by plating serial dilutions of
phage stocks with the suppressor strains. The strains used
were TP278 , TP279 , TP280 , TP282, TP308, TP320 and TP309. The
strains were kept as glycerol stocks at -20 C. A working stock
would be prepared by streaking 10 l of the glycerol stock on
an LB plate and incubating it overnight at 30 C. Single
colonies were selected from these plates and streaked on
minimal plates that were supplemented with either ampicillin
(TP278 , TP279, TP280, TP320 and TP282) or ampicillin plus
tetracycline (TP308 and TP309). The plates were incubated at
C for 24 hours. Single colonies were used to inoculate 5
ml of M9 plus and antibiotics. It was important to grow
liquid cultures of TP308 and TP309 in M9-glucose minimal
medium supplemented with antibiotics because the plasmids that
encoded the suppressor tRNA' s were readily lost if selection
was not maintained. These cultures were aerated at 30 C until
they reached a cell density of about 1 x 10 /ml. The cultures
were then used to plate P22 19am phage. The infections were
done by adding 100 l of phage suspended in BS to 0. 5 ml of
the bacterial culture. The phage were allowed to adsorb to
the cells for 15 minutes at room temperature and then 2. 5 ml
of soft agar at 50 C was added, the suspension was gently
vortexed and poured onto lambda plates. Infections using TP308
or TP309 were plated on tetracycline-containing LB plates. The
soft agar was allowed to harden, about 5 minutes at room
temperature and then the plates were incubated overnight at
either 30 or 40 Usually 0. 1 ml of the dilutions used
contained 100 to 1000 phage, unless it was previously known
that a given mutant phage would not plate efficiently on a
particular suppressor strain. In such a case between 1000 and
100, 000 phage were used for the infections.
Resul ts
si te Directed Mutagenesis. Seven amber mutations were
introduced into P22 gene 19 by site directed mutagenesis,
replacing codons 12 (lysine), 22 (tyrosine), 39 (valine), 61
(glutamate), 65 (tryptophan), 82 (glutamine) and 83
(tyrosine) . Three variations of the basic protocol outlined
in the Materials and Methods section were employed. The amber
mutations were introduced by extension of mutagenic primers
hybridized to plasmid-borne gene 19. Once the mutant plasmids
were identified , the mutations were crossed onto the P22
genome. A defective P22 phage which was oversized and 19- was
used for this cross. Recombinant phage were selected and the
genes containing the amber mutations in gene 19 were
sequenced.
suppression patterns of phage with gene 19 amer
mutations. The suppression patterns of the eleven mutant
phage were determined at 30 C and 40 C. The following section
shows the individual suppression patterns for each of the
mutant phages. The ability of each phage to form a plaque is
indicated by + and - signs. If the phage forms normal sized
plaques with an efficiency of greater than 0. 5, relative to
its plaque forming ability on TP320 then it is designated by
++; if the phage forms pinpoint plaques or plates with an
efficiency of 0. 01 to 0. 5 then it is designated by +; if the
phage plates with an efficiency between 10-5 and 0. 01 then it
is designated by +/- ; if the phage plates with an efficiency
of less than 10-5 then it is designated by - The suppressor
strains used were TP278 (gln) , TP279 (tyr), TP280 (leu) ,
TP282 (ser) , TP308 (phe), and TP309 (cys). They are designated
below by the amino acid inserted by the suppressor tRNA. See
Table 5 for a compilation of all the suppression patterns.
Suppression Pattern for Phage with 19am12 (lys) Mutation.
qlu tyr leu ser phe
+/-
cvs
+/-
The suppression pattern of P22 19am12 (lys)
indicates that of the 6 different amino acids substituted at
residue 12 , the phenylalanine and cysteine substitution have
the greatest effects on the function of lysozyme. The
substitution of glutamine at 40 C results in slightly less
lysozyme activity since the plaque size is affected but the
efficiency of plating is normal. Lysine residues are usually
found at a molecular surface , though sometimes they are found
in internal salt bridges or are involved in catalysis. It is
not surprising that phenylalanine can not substitute for
lysine , since phenylalanine is usually found at the inside of
protein molecules. Leucine is a large nonpolar residue that
is normally found inside, but it can substitute quite well for
lysine at this position. The suppression pattern indicates
that the substitution of cysteine for lysine results in the
most severe defect of the six substitutions.
suppression Pattern for Phage with 19am22 (tyr) Mutation.
gln tyr leu ser phe cvs
++'
The suppression pattern for P22 19am22 reveals the
effect of five different amino acid substitutions for
tyrosine. Of the five substitutions , only phenylalanine yields
a protein that is comparable to wild type at 30 C and 40
Suppression Pattern for Phage with 19am39 (val) Mutation.
qln tvr leu ser phe cvs
+/-
The suppression pattern of P22 19am39 (val) indicates
that five of the six substituted amino acids yield functional
lysozyme. The substitution of cysteine for valine yields a
protein with reduced acti vi ty . It is possible that the
cysteine forms crosslinks with other cysteines blocking
formation of the normal structure. This is unlikely though
since the interior of the bacterial cell is thought to have a
reducing environment. This position does not appear to be very
critical to lysozyme.
"'"
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Suppression Pattern for Phage with 19am61 (glu) Mutation.
qln tyr leu phe cvs
The suppression pattern for P22 19am61 shows that this
glutamate is not a critical residue for the protein. Five of
the six substitutions yield a lysozyme with normal activity.
suppression Pattern for Phage with 19am64 (gln) Mutation.
qln tvr leu ser phe cvs
7.;
The suppression pattern for P22 19am64 (glu)
demonstrates that the glutamine at position 64 is not a
critical residue for P22 lysozyme. All five substitutions
yield functional lysozyme. The cysteine in this case does not
seem to interfere with the protein structure or function as is
the case with most of the other positions studied.
Suppression Pattern for Phage with 19am65 (trp) Mutation.
gln tyr leu ser phe cvs
The suppression pattern determined for P22 19am65
(trp) indicated that this residue is another noncritical
residue for P22 lysozyme. only the cysteine has a significant
effect on the activity of the protein. The suppression
pattern was the same for both the site directed and the
chemically induced amber mutations at this site.
Suppression Pattern for Phage with 19am80 (gln) Mutation.
aln tvr leu ser ohe cvs
+/-
The suppression pattern for P22 19am80 (gln)
demonstrates that this position in P22 lysozyme has some
constraints as to what type of residues will be tolerated.
Once again the cysteine substitution is not tolerated well.
Additionally there is an intolerance for the two aromatic
amino acids. It is possible that the lack of flexibility or
size of the aromatic rings is unacceptable at this position.
Suppression Pattern for Phage with 19am82 (gln) Mutation.
aln tvr leu ser ohe cys
+/-
The amber mutation at position 82 (gln) of P22 19
allows us to investigate the effect of five different amino
acid substitutions at this position. Of these five
substitutions , only leucine yields a functional protein at
high and low temperature.
Suppression Pattern for Phage with 19am83 (tyr) Mutation.
qln tvr leu ser phe CYS
+/-
The suppression pattern of P22 19am83 (tyr) indicates
that only the aromatic phenylalanine can be substituted for
tyrosine and still yield a completely functional protein.
glutamine substitution yields a temperature sensitive protein.
Suppression Pattern for Phage with 9aml13 (gln) Mutation.
qln tvr leu ser phe cys
The glutamine at position 113 f P22 lysozyme does not
appear to be a critical residue since all five substitutions
yield effective proteins. The phenylalanine and cysteine
substi tutions cause a change in plaque size but not in the
efficiency of plating. This indicates that the protein is not
as efficient as wild type but does still function. The phage
bearing the amber muation at position 133 also has an amino
acid change at position 112 (see chapter 2). The question of
the importance of the change at position 112 that resulted in
a tyrosine codon being changed to a serine codon was
investigated. Five other independently isolated amber
mutations mapped to the same location in gene 19 by
recombination tests 19am-H736 , 19am-Hl195 , I9am-H1212, 19am-
H1299 , and 19-amH1344. All of these phage have the same
suppression patterns as P22 19aml13 that was sequenced. It
would be highly unlikely that all had undergone the same type
of double mutation.
Suppression Pattern for Phage with 19am122 (trp) Mutation.
qln tvr leu ser phe cys
The suppression pattern for P22 19am122 (trp)
indicates that at 30 C five of the six amino acid
substitutions yield lysozymes with normal activity. The
phenylalanine and cysteine substitutions are temperature
sensitive.
Discussion
By examining the phenotypes of proteins with known
substitutions one can determine which residues of the protein
are neutral , in the sense that a substituted amino acid has no
discernible effect on the protein' s function. The functional
test used in this study is the ability of P22 to form a plaque
of normal size and with normal efficiency. We have some idea
of how much lysozyme acti vi ty is needed to form a plaque.
hybrid P22 which has bacteriophage T4 lysozyme gene
substituted for the P22 lysozyme gene forms a normal plaque.
The amount of lysozyme produced by this hybrid during a single
cycle of infection was compared to the amount produced by wild
type P22. wild type P22 produced 30 fold more lysozyme
activity. since the hybrid phage makes a wild type size
plaque , then we can assume that P22 normally produces excess
lysozyme. In order to see an effect of an amino acid
substitution we must reduce the specific activity more than 30
fold (L. Hardy, personal communication).
From the suppression patterns presented in Table 5 , it
is apparent that the majority of the positions studied for P22
lysozyme can tolerate amino acid substitutions. Of 60
possible substitutions at 11 positions only 18 reduced the
efficiency of plating of the phage at 30 C. When the
temperature was raised to 40 , 7 more substitutions reduced
plating efficiency. Only 7 of the 60 possible substitutions
resul t in a defect in lysozyme severe enough that the phage
plates with the same efficiency on su+ as on su- when the
plating is done at 30 This demonstrates a large degree of
tolerance , since the substituted amino acid side chains are
branched and nonpolar (leucine), large , aromatic, and nonpolar
=t -
(phenylalanine), polar and neutral (cysteine
, serine, and
glutamine) , and polar and aromatic (tyrosine). Since amino
acids such as leucine or phenylalanine
, which are usually
found buried within a protein , affect the function of lysozyme
very little when substituted for amino acids that are normally
found on the molecular surface of a protein
, such as lysine
(position 12) or glutamate (position 61), it appears that a
protein can make adjustments for very different types of amino
acids at certain positions.
By examining the frequency of amino acid changes
between correspond lg proteins of different species "exchange
groups" have been defined (G. E. Schulz and R. H. Schirmer
1984). The amino acids wi thin such a group exchange
preferentially with each other. There are four exchange
groups: 1. aromatic side chains-phenylalanine , tyrosine , and
tryptophan. 2. positively charged side chains- lysine
arginine , and histidine. 3. large aliphatic nonpolar side
chains-valine , leucine , isoleucine , methionine, and cysteine.
and 4. small side chains regardless of polari ty- threonine
aspartate , asparagine , glycine , alanine , glutamine , glutamate
and proline. If one examines the substitutions that were
neutral (had less than a 30 fold decrease in activity) in P22
lysozyme , it becomes obvious that amino acid substitutions
from different exchange groups can be tolerated, even when a
substitution from the same exchange group is not acceptable.
,,-. .
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For instance , both cysteine and valine belong to the same
exchange group, yet when the 19am39 (val) is substituted with
a cysteine , a marginal lysozyme results. Yet this valine can
be substituted with members of the other three exchange groups
(glutamine , tyrosine , serine, and phenylalanine) with no
reduction in activity.
These examples demonstrate the necessity of a more
comprehensive study of protein structure. The rules that have
been formulated to date clearly have many exceptions.
Possibly by undertaking a more extensive study of which
substitutions are allowed at any given position in a protein
rules could be deduced that would have fewer exceptions.
survey, such as the one outlined here, and the one done on lac
repressor (Miller et al, 1979) could be easily broadened using
the methods developed in this survey.
The site directed mutagenesis procedures outlined
allow one to create an amber mutation at any given location in
a gene. A complementation test to distinguish the mutant
transformant was helpful since the efficiency in recovering
the mutation was only in a range of 1 to 10%. This efficiency
can be increased using a gapped circular ds DNA molecule as
template in the extension ligation reaction (L. Hardy,
personal communication).
Amer mutations allow one to insert any amino acid for
which a suppressor tRNA is available. Suppressor tRNAs for all
the amino acids might be available in the near future since
Abelson and Miller are currently trying to construct in vitro
all the possible suppressors (Normanly et al 1986). This
would mean that all substitutions could be examined just by
growing an phage bearing an amber mutation on a battery of
suppressor strains.
plasmids
pTP289
pDR321
pDR281
pDR3 9 2
pDR463
pDR464
pDR401
TABLE 4
PLASMIDS
Ligation of the HindIII-BamHI replication origin
fragment from pBR322 with the BamHI-NaeI fragment
from pDR100 containing the carboxy-terminal portion
of gene 19 , and a fragment containing the amino-
terminal portion of gene 19 generated by digesting
pDR110 with EcoRI, filling in the ends , and
digesting with HindIII. BgIII linker (5' CAGATCTG
) is inserted between the NaeI and filled-in EcoRI
ends. This plasmid was constructed by D. Herrick.
This plasmid was used to construct a P2 2 defectivelysogen. Insertion of the large internal HpaI
fragment of Tn5 into the site created by digesting
pTP289 with BgIII and filling in.
This plasmid was used as template for. in vitro
mutagenesis. Ligation of EcoRI-BamHI lysozyme
containing fragment from pDRl18 and EcoRI-BamHI
origin containing fragment of pZ152 (Berman).
This plasmid was used as template for in vitro
mutagenesis. Three fragments ligated together:
1. ClaI (filled in) -BamHI lysozyme-containing
fragment of pDRl16; 2. PstI-PvII P fragment
from pTP30; 3. PstI-BamHI M13 origih 8f replication
containing fragment from pTP352.
Thift plasmid produces Phe sup tRNA and is tet
R and
amp . pGFIB:Phe (Normanly et al , 1986) was digested
with ClaI and filled n then ligated with EcoRI(filled in) -PvuII tet fragment from
pBR322.
Thift plasmid produces Cys sup tRNA and is tet
R and
amp . pGFIB:Cys (Normanly et al, 1986) was digested
with aI and filled n then ligated with EcoRI(filled in) -PvII tet fragment from
pBR322.
A p asmid used i gapped circle mutagenesis.tet , amp , lyso pDR392 EcoRI-BamHI (both
ends filled in) fragment containing lysozyme
was ligated into the filled in EcoRI site of
bearing an ochre mutation in the -lactamase
It is
gene
pBR322
gene.
TABLE 5
SUPPRESSION PATTERNS OF PHAGE BEARING AMBER MUTATIONS IN
GENE 19
am12(lys)
am22(tyr)
am39(valO
am61(glu)
am64
gln)
am65(trp)
am80(gln)
am82(gln)
am8 3(tyr)
aml13(gln)
am122
trp )
gln tvr leu phe
+/- +/-
cysser
. ++ /-+/-
Table 5. Suppression pattern of P22 phage bearing amber
mutations in gene 19. The amino acids inserted by TP278
(gln) , TP279 (tyr) , TP280 (leu), TP282 (ser) , TP308 (phe), and
TP309 (cys) are shown across the top. The 19 alleles are
shown on the left side with the original amino acid at that
position shown in parenEhesis. The top line for each allele
repreBents titers at 40 C. The bottom line represents titersat 30 C. The symols represent titers on the suppressor tRNA
strain relative to the titers on a lysozyme-producing strain(TP320). A ++ symol indicates normal plaque size and a
ratio of titer of su+/ TP320 of greater than 0. 5. A single +
sign indicates pinpoint sized plaques or a ratio of between
01 and 0. 5. A +/- symol indicates an a ratio of titers
between 0. 0001 and 0. 01. A minus symol means that the titer
on the su+ strain was the same as on the su- strain.
plasmid
gene 19
phage
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Figure 5. Homologous recombination between plasmid and
phage to create a defective P22 phage. The Tn5 insertion
5 kb and it interrupts the coding sequence of gene 19.
FIGURE 6
RECOMBINATION BETWEEN AMBER-BEARING PLASMIDS AND P22
gene 19 plasmid
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gene 19
homologous recombination and induction with mitomycin C
yields a recombinant phage with the following structure:
::::::::::::::::::. .: ..:.:.:. . . . . . :.:.:
::/:::X::
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gene 19am
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Figure 6. The recombination between the amber bearing
plasmid and the defective prophage to yield an amber bearing
phage. The phage has lost the Tn5 insertion and has
acquired the amber mutation. If the first crossover point
occurred 3' to the amber mutation then a wild type phage would resul t .
FIGURE 7
GAPPED CIRCLE MUTAGENESIS
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Figure 7. Gapped circle mutagenesis. The substrates shown on the top half
of the page are denatured and reannealled. An extension ligation reaction
is done resulting in the structure shown on the bottom of the page. This
heteorduplex has mismatches in -lactamase and in gene 19. Since the
strand containing the amber in 19 is methylated, then upon transformation
the cell' s repair system should selectively correct to this sequence , thus
yielding a double strand plasmid with a functional amp and tet resistance
gene and an amber in 19.
The other structures formed ill be parental and have either an
ochre in 
-lactamase or a truncated tet gene. These will not be viable
when selected on amp + tet plates.
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CHAPTER IV
SECOND SITE REVERTANTS OF MISSUPPRESSED P22 GENE 19 AMBER
MUTATIONS
Introduction
This chapter describes how second site intragenic
revertants of "missuppressed" amber mutations in P22 gene 19
were isolated and characterized. I use the term
missuppressed" to designate phage bearing amber mutations
that, when used to infect a strain containing a particular
amber suppressor fail to form normal sized plaques at normal
efficiencies due to detrimental affects of amino acid
substitutions at the position of the amber mutation in P22
lysozyme.
As discussed in the previous chapter, the 60 amino acid
substitutions at 11 different positions of P22 lysozyme
yielded a considerable amount of information about which
residues were critical to the structure/function of lysozyme.
As interesting as that information is , it does not allow one
to understand how a protein assumes or stabilizes its tertiary
structure. Since all the information most proteins need to
obtain their final structures is contail1ed. in the primary
amino acid sequence, it stands to reason that these blueprints
must operate by specific interactions between the amino acids.
By studying which interactions occur, understanding of the
blueprints might come about. One approach to deciphering
these interactions is to identify individual interactions that
are critical for the protein' s structure/ function.
isolating second site intragenic revertants of missuppressed
amber mutations , pairs of amino acids that interact with one
another in direct or indirect fashions are identified.
The survey of amber mutations in P22 lysozyme yielded 
combinations of site and suppressor that resulted in reduced
or undetectable lysozyme acti vi ty. Revertants that restored
activity were isolated from these missuppressed amber
mutations. The revertants were screened to determine whether
the site of the reversion was primary or secondary. This
screen , which is critical to the success of the project , was
fast and efficient due to the nature of the primary mutations.
The revertants of missuppressed - Jnber mutations either still
contain amber mutations (second site revertants) or no longer
contain the amber mutation (primary site revertants). Hence
if the revertant phage requires a suppressor tRNA to grow, the
reversion was a second site reversion. On the other hand , if
the revertant phage can grow in the absence of a suppressor
tRNA, the reversion event was a primary site reversion.
Secondary site revertants were identified and the the sites
containing the mutations were sequenced. Some interactions
that take place between amino acids of P22 lysozyme were
identified.
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Materials and Methods
P1asmids. Plasmids were constructed using standard in
vitro DNA techniques (Maniatis et al. , 1982). Plasmids pDR469
pTP400, and pTP399 are described in detail in Table 6. Plasmid
pDR469 was used in construction of a defective P22. This
plasmid has a 5. 04kb fragment of Tn5 DNA encoding kanamycin
resistance inserted between P22 DNA that consists of the 
half of gene 13 , the first 9 codons of .gene 19 and the last 13
codons of gene 19 with 250 bases of DNA 3' of gene 19. other
plasmids were described in chapter 
Enzymes, chemicals, media, and buffers. The enzymes
chemicals , media , and buffers are as described in Chapter 
Construction of P22 sieA44 m44 Kn469. A defective P22
prophage that lacked gene 19 was used to cross mutant alleles
from plasmids onto unmutagenized P22. Plasmid pDR469 was used
to transform Salmonella su- r- m+ (MS1868) to kanamycin
resistance. This strain was then grown to a cell density of 1
x 10 /ml in LB broth suplemented with ampicillin and kanamycin
at 370 C. The culture was then infected with P22 sieA44 m44
at a MOl of 10 and aerated for 2 hours at 37 C. Chloroform was
added and the debris was removed by centrifugation at 5900 g
for 5 minutes. The resulting lysate was titered on TP284.
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Salmonella polA-ts strain (CVl12) grown to a cell density of 1
x 10 /ml in LB broth at 300 C was infected with the lysate
(MS1868/pDR469 + P22 sieA44 m44) at a MOl of 10, the phage
were allowed to adsorb for 15 minutes and the infected cells
were spread on kanamycin LB plates and grown at 370 The
colonies were screened for ampicillin sensitivity, P22
immunity, and the ability to yield plaque-forming phage.
Colonies which were amp , P22 immune, and could not yield
phage, were selected. The procedures used for the above tests
are described in Chapter A liquid culture of the selected
clone was grown in LB broth supplem nted with kanamycin to a
cell dens cy of 1 x 10 /ml at 37 0 C and then mitomycin C was
added and the culture continued to be aerated for 3 hours at
0 C. A lysate was obtained after treating the cells with
chloroform and HEWL and then centrifuging at 5900 g for 5 rnin
to spin the cell debris out. The lysate was used to infect a
Salmonella F'-bearing strain (MS1387 (del attP22J cysB his
leuD fol101 \ F' lac pro), in which the only P22 attachment
site is episomal. Lysogens were selected by spreading the
infected cells on kanamycin plates. The colonies were
screened for P22 immunity and inability to yield plaque-
forming phage. A colony that passed these tests was used to
mate with E. coli (W3110). The defective P22 prophage was
thus transferred to an E. coli strain. The lysogen was
selected on minimal. plates supplemented with kanamycin.
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Colonies were tested in the same manner as described above.
Isolation of Revertants. Revertants of missuppressed amber
mutations were isolated in three different ways. Spontaneous
revertants were recovered by plating phage bearing amber
mutations on suppressor strains that yielded lysozyme that had
less than wild type activity. The number of phage plated to
detect spontaneous revertants depended upon the plating
efficiency of the given phage on that particular suppressor
strain. For instance, if a 19am phage stock had 1 x
10 pfu/ml but would only form plaques on a given suppressor
-6 strain at 1 x 10 , then about 2 x 10 pfu would be plated.
This would yield about 200 plaques. On the other hand , if a
stock had 1 x 10 pfu/ml but would plate with an efficiency of
1 on a given suppressor strain, forming pinpoint sized
plaques , then 500 phage would be plated.
Any larger plaques from the background of pinpoints
would be screened for primary or secondary site reversion.
Such plaques would be replated by transferring phage from the
center of the plaque to plates that had fresh bacterial lawns
of the suppressor strain, a suppressor-minus strain and TP320.
If the plaque being tested yielded phage that failed to grow
on a suppressor-minus strain , grew on TP320, yet plated better
than the original mutant phage on the suppressor plus strain,
then it was a candidate for a second site revertant. The T4
lysozyme-producing, suppressor-minus strain TP320 was used to
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screen for phages that had reverted the original amber
mutation in gene 19, yet picked up other amber mutations in
other essential P22 genes. These phages will not grow on
TP320.
Only combinations of mutant phage and suppressors strains
that exhibited plating efficiencies of less than 1 x 10-3 as
compared to the same phage' s titer on a permissive strain were
useful for finding spontaneous revertants.
Revertants were also isolated from" phage that had
undergone UV mutagenesis. The UV irradiation was performed by
suspending 1 x 1010 phage in 1 ml of BS in an open glass petri
dish and exposing it to 3500 ergs/mm2 UV light at 254 nm as
measured by "Black Ray" dosimiter from Ultra violet Products.
The phage were transferred to foil wrapped glass tubes and
stored at 4 C. This treatment typically reduced the titer of
the phage by a factor of 10 to 10 , with 1-4% clear plaque
formers among the survivors. The UV-irradiated phage were
plated (enough live phage to yield no more than 200 plaques)
on UV-stimulated (300 ergs/mm ) suppressor strains which bore
pKM101 amp (Youderian et al., 1982). This is the procedure I
shall refer to as "direct plating" An alternative method was
cycling" or passaging phage though one suppressor strain and
using the lysate to infect another suppressor strain. cycl ing
was done by infecting 1 ml cultures pKM101 amp -bearing, UV-
stimulated suppressor cells at a density of 1 x 10 /ml, with 1
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X109 UV-irradiated phage, allowing 20 minutes for adsorption
then diluting into 50 ml of LB broth and growing at 30 C or
C for 2-6 hours. Chloroform (1 ml) and HEWL was added and
the debris was pelleted by centrifugation at 5900 g for 5 min.
The resulting lysate was plated on missuppressing suppressor
strains on lambda plates. Revertants were screened in the
same manner as previously described. strains bearing pKM101
were UV-stimulated before infection so that 
mucA and mucB
would be induced. The induction of these genes produced 10-40
fold increases in the titer of the UV-irradiated phage stocks.
plasmid. Appendix 1 shows typical results of UV-stimulated
This reactivation was dependent on the presence of the pKM101
mutagenesis.
sequencing the Revertants. The sequencing was done in
the manner described in the previous chapter. The parent
, '
phage bearing an amber mutation in gene 19 was sequenced side
by side with the revertant phage. All revertants were
sequenced from 32 bases 5' of the start site of gene 19 to 25
bases 3' of gene 19. The original amber codon was confirmed
in all cases.
Backcrossing the Mutations. The mutations present in
gene 19 were subcloned and then backcrossed to an
unmutagenized P22. DNA was extracted from O. 4 ml of phage
stock by the procedure outl ined in Chapter The DNA was
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digested with HpaI endonuclease in a reaction that contained
50 l DNA (0. l), 14 units of HpaI 10 l 10 x HpaI
buffer and 4 l of H 0. The digestion was carried out at 37
for four hours and then checked on 0. 7% agarose gels. I f the
digestion went to completion , the reaction was terminated by
phenol extraction, ether extraction , and ethanol
precipitation. The DNA was resuspended in 4 l of DB , and
after the addition of 5 l sample buffer, the mixture was
electrophoresed on a 5% bis-acrylylcystamine-crosslinked
polyacrylamide gel (Hansen, 1981) at 150 volts until the
bromophenol blue migrated to the end of the gel. The HpaI
fragment of 1. 1 kb (band G) that contained gene 19 was excised
from the gel and the DNA was extracted following the protocol
of Hansen (1981). The HpaI fragment was ligated with pBR322
that had been digested with EcoRV. The ligation reaction
mixture was used to transform W3110 to ampicillin resistance.
The colonies were checked for tetracycline sensitivity.
Tetracycline sensitive colonies were picked and 5 ml liquid
cultures were grown in LB plus ampicillin. DNA was isolated
from minilysates and the size of the plasmids was determined
by electrophoresis on a 0. 7% agarose gel using pBR322 as a
size standard. Plasmids that were larger than pBR322 by about
1 kb were identified.
These plasmids were then used to transform TP315 to
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ampicillin resistance. TP315 is W3110 with a P22 siea44 m44
Kn469 prophage. A clone was selected and grown in 50 ml of LB
until a cell density of 2 x 10 /ml was reached and then the
culture was induced with 40 l of mitomycin C (0. 4 mg/ml) for
three hours at 37 Chloroform and HEWL was added and the
aeration at 37 C continued for 20 minutes. The debris was
spun out by centrifugation at 5900 g for 5 minutes.
The resulting lysates with 1 x 10 /ml P22 tails added
were used to infect Salmonella suppressor strains which were
permissive for the amber being tested. The infections were
done using 0. 1 ml of the lysate or 0. 1 ml of a 100-fold
dilution of the lysate and 0. 5 ml of cells at 2 x 10 /ml.
dertermine linkage of the secondary phenotype 50 single plaque
lysates were made from the plaques that resulted. Dilutions
of the single plaque lysates were spotted on suppressor-minus
cells, suppressor cells that missuppressed the original mutant
phage , and permissive suppressor cells. The spots were scored
for the secondary phenotype. Suppression patterns and plaque
morphologies of these reconstructed second site revertants
were then compared to those of the original second site
revertants and to the original mutant phage.
1 .
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Resul ts
All combinations of P22 19am phage and suppressor
strains that resulted in reduced lysozyme acti vi ty were
screened for second site reversion. It became apparent that
second site reversion was much rarer than primary site
reversion. This result was presumably not due to any
particular targeting of the amber codons by the mutagenesis
procedure , since UV mutagenesis used in conjunction with
pKM101 has the broadest spectrum of any mutagen available
(Coulondre and Miller , 1977; Youderian et al. , 1982).
Therefore , I feel that the scarcity of second site revertants
for certain alleles reflects the lack of sites that can
compensate for the original substitutions. The relative
frequencies of primary and secondary site revertants among
plaque-formers on the missuppressing hosts varied greatly,
second site revertants represented only 0. 1-20% of total
revertants depending upon which allele was being reverted (see
Table 2).
Spontaneous Revertants. The first method used to
isolate second site revertants was by plating unmutagenized
19am phage directly with the missuppressing strains.
Spontaneous revertants that grew were screened for primary or
second site reversion. Since reversion rates for most of the
19am phage ranged between 10 
5 or 10
, and no more than 1000
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plaque-forming phage could be plated on a single plate , the
only combinations that were tried in this fashion were ones
that had an EOP of less than 0. 001. All the revertants were
primary site revertants. The combinations and the results
were as follows: The ratios represent second ' site
revertants/primary site revertants.
ressor strains
TP280 (leu) TP308 (phe) TP309 (cys)
am12 (lys) 0/5
am22 (tyr) 0/50
am22 (tyr) 0/50
am39 (val)
am80 (gln) 0/50 0/5
Normally on any given plate I would have between 5 and
20 revertants for the combinations given above. If I tried to
plate more phage per plate , the bacterial lawn would die
before the phage grew. The number of phage per plate depended
upon the combination of phage and suppressor being plated , but
the normal range for the alleles described above was between
5 and 107 phage per plate.
Revertants Obtained by Direct Plating of UV-Irradiated
Phage. Revertants were isolated after UV-irradiation and
direct plating. These conditions made it possible to recover
revertants with less plating. The most common problem I
encountered in these experiments was that the "dead" phage in
the dilutions would inhibit the growth of the bacterial lawn.
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This was probably due to the large number of phage particles
adsorbing to the bacterium, even though the particles had
defective genomes due to the mutagenesis or the formation of
lysogens. When the reversion rate of the amber mutation was
high enough , then revertants could be recovered by plating
less total (dead or alive) phage and the bacterial lawn would
be intact. A summary is given in table 
P22 19am12 (lys) was plated on TP278 (gln) , TP308 (phe) ,
and TP309 (cys). The TP308 (phe) and TP309 (cys) platings yielded
about 50 plaques each , and all were primary revertants.
obtaining revertants on TP278 (gln) was more difficult since
the parent made a small plaque. Only 32 revertants were tested
and all were primary revertants.
P22I9am22 (tyr) was plated on TP278 (gln) , TP280 (leu) 
TP282 (ser) , and TP309 (cys). All revertants tested (350 each
condition except for TP309 (cys), for which only 100 were
tested) were primary or primary plus a secondary site
extragenic revertants. The secondary site extragenic
revertants were ambers in other P22 essential genes that would
grow on the missuppressing strains. These were isolated in
combination with primary revertants in gene 19. They were
distinguished from intragenic secondary site revertants by
plating on TP320. Because this strain is su- but lysozyre+
it does not plate the extragenic ambers.
P22 19am39 (val) was plated on TP309 (cys) and 14 of 50
revertants were secondary site revertants. Two of these
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secondary site revertants (19am39sr575 and 19am39sr581) were
sequenced and both had changes only in the ribosome binding
site of gene 19. These secondary site revertants were not
further characterized.
I did not try to isolate revertants for P22
19am61 (glu), 19am64 (gln), and 19am65 (trp) since the
suppression patterns indicated that these phage grew fairly
well in the suppressor strains.
Revertants were isolated from P22 19am80 (gln) on
TP279 (tyr) , TP308 (phe), and TP309 (cys) From each condition
100 revertants were screened. All were primary revertants.
P2219am82 (gln) was plated on TP279 (tyr), TP282 (ser) ,
TP308 (phe), and TP309 (cys). On TP279 (tyr) , 750 revertants were
screened they were all either primary or primary plus
extragenic revertants. There were 600 revertants screened
from platings on TP282 (ser), all were primary site revertants.
I screened 50 revertants from TP308 (phe) and TP309 (cys). These
were all primary site revertants.
Revertants of P22 19am83 (tyr) were obtained on
TP278 (gln) , TP280 (leu), and TP282 (ser) . Of the 500 revertants
screened from TP278 (gln) all were primary revertants. Of the
350 revertants from TP280 (leu) all were primary revertants.
There were 200 revertant from TP282 (ser) that were screened
and all were primary revertants.
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Revertants Obtained by "cycling" UV-Irradiated Phage.
Phage were subjected to UV mutagenesis and then used to infect
UV-stimulated permissive or semi-permissive suppressor
strains. The infected cells were incubated for at least 2
hours so that multiple rounds of infection would take place.
Lysates were prepared from these cultures and used to infect
missuppressing strains. Revertants that arose on the
missuppressing strains were screened for primary or secondary
site reversion. Revertants obtained in this manner are not
independent; therefore when secondary site revertants were
found in a given lysate, only one would be characterized
unless there were differences in plaque morphology between
individual revertants. A summary is given in Table 
Phage 19am22 (tyr) was passaged on TP282 (ser) and
TP278 (gln) The lysates were plated on TP280 (leu) and
TP278 (gln) Revertants were screened for secondary site
reversion. The lysate passaged though on TP278 (gln) yielded
only primary site revertants, 150 on both TP280 (leu) and
TP278 (gln) The lysate passaged on TP282 (ser) yielded second
site revertants when plated on TP280 (leu) . There were 16
second site revertants from the 50 plaques that were tested.
Of the 16 second site revertants, 2 were picked for further
study: 19am22 (tyr) sr517 and 19am22 (tyr) sr520. Only primary
revertants (18) were found when the lysate was plated on
TP278 (gln) 
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Phage 19am82 (gln) was irradiated with UV and then
passaged on TP282 (ser) , TP279 (tyr) , and TP278 (gln). Phage
lysates were prepared from these infected cultures and used to
plate for revertants on TP279 (tyr) and TP282 (ser) . From the
lysate passaged on TP279 (tyr) which was plated on TP282 (ser) ,
50 revertants were screened, all of which were primary
revertants. When this phage was passaged on TP278 (gln), a
permissive strain 50 revertants were selected on both
TP279 (tyr) and TP282 (ser) . All were primary site revertants.
A lysate passaged on TP282 (ser) was used to select revertants
on TP279 (tyr) and TP282 (ser) . The 150 revertants on
TP279 (tyr) were primary revertants. From he 100 revertants on
TP282 (ser) there were 5 secondary site revertants. The plaque
morphology of at least three of the secondary site revertants
differed enough from each other to consider them individually
(19am82 (gln) sr512 , 19am82 (gln) sr513 , and 19am82 (gln) sr516) .
Two additional secondary site revertants were chosen:
I9am82 (gln) sr514 and 19am82 (gln) sr515.
Phage 19am83 (tyr) was passaged on TP278 (gln) and
TP280 (leu). The lysate passaged on TP278 (gln) was used to
infect TP280 (leu) . Two hundred revertants were screened; 29
secondary site revertants were found. The one chosen to
characterize was 19am83 (tyr) sr542. This lysate was also used
to infect TP278 (gln) . Fifty revertants screened , and 18 were
secondary site revertants. The lysate passaged on TP280 (leu)
was used to infect both TP280 (leu) and TP278 (gln) . Fifty
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revertants were screened for both conditions
, 7 secondary site
revertants were found out of the 50 tested when the lysate was
plated on TP278 (gln) . Of the 50 plaques tested from the
TP280 (leu) plates , 12 were secondary site revertants. One
revertant was chosen to characterize: 19am83 (tyr) sr532.
The collection of secondary site revertants isolated
consists of 9am82 (gln) sr512, 19am82 (gln) sr513
9am82 (gln) sr514, 19am82 (gln) sr516, 19am22 (try) sr517
19am22 (tyr) sr520 , 19am83 (tyr) sr532, 19am83 (tyr) sr542,
19am39 (val) sr575, and 19am39 (val) sr581.
Suppression patterns of the second site revertants.
The suppression patterns of the second-site revertants are
shown in Table 9. The changes seen in all of the secondary
site revertants are improvements in the plaque-forming ability
of the phage. In no case did a second site change decrease
the phage I s abil i ty to form a plaque with a given
substi tution. In theory, one could expect some secondary
changes to improve the plating ability of the phage on the
missuppressing strain but at the same time decrease the
ability of the phage to plate on a previously permissive
strain. It was thought that a change which increased and
decreased the plaque-forming ability of the phage
, depending
upon which amino acid was being substituted
, would demonstrate
that the secondary site change was an allele-specific change
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and not just a change which increased the protein' s overall
stability. The suppression patterns of the secondary site
revertants indicate that the revertant phage can plate on
missuppressing strains other than the one it was isolated on
or cycled on, yet the improvements are not across the board
since there are still missuppressing strains in which the
phage show no improvement. For instance , 19am83 (tyr) sr532 was a
result of cycling 19am83 (tyr) in TP280 (leu) and then picking a
revertant from TP280 (leu), yet it shows a marked improvement
in its plating ability on TP278 (gln) . The same is true for
19am22 (tyr) sr517. It was cycled and picked on TP282 (ser) , yet
shows improvement n TP278 (gln) 
Sequences of the revertants. I had three classes of
revertants: 1. nucleotide changes that resulted in an amino
acid change in lysozyme 2. nucleotide changes in gene 13 that
resulted in a change in the vicinity of the ribosome binding
si te of gene 19 and in some cases caused an amino acid change
for p13, and 3. No nucleotide changes found in the DNA
sequenced.
Most of the revertants had more than one change (see
Table 10). The revertants that had changes in the ribosome
binding site were presumed to be regulatory mutants and were
not further characterized. These included 19am39 (val) sr575,
19am39 (val) sr581, 19am83 (tyr) sr532 , and 19am83 (tyr) sr542. Two
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second site revertants , 19am22 (tyr) sr517 and 19am82 (gln) sr515
had no nucleotide changes in gene 19. The - revertants that
showed changes in gene 19 were 19am82 (gln) sr512
19am82 (gln) sr513 , 19am82 (gln) sr514, 19am82 (gln) sr516 , and
19am22 (tyr) sr520.
Backcrossinq the second-site revertants. Since the
revertant phage had undergone extensive UV- irradiation , it was
possible that the phenotypes observed were not due to the
changes present in gene 19, but were due to changes elsewhere
in the phage genome. since lysozyme appears to act
independently as a monomeric protein I did not expect to
recover revertants that had compensating changes in other
phage proteins with which lysozyme acts. It was possible
however, that changes in the amount of transcription from
Late ' changes in the stability of the mRA, or changes in an
unknown gene, might increase synthesis of the missuppressed
lysozyme or bypass the need for lysozyme. Two classes of the
sequenced revertants are apparently extragenic: the revertants
with changes in the ribosome binding site and revertants with
no changes found. To rule out any affects of extragenic
mutations from the sequenced intragenic revertants, I
reconstructed the secondary site revertants by removing a 1.
kb HpaI fragment containing part of gene 13 and all of gene 19
from the revertant phage and cloning it into a plasmid. The
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resul ting plasmids were then used to cross gene 19 alleles
onto P22 sieA44 m44 using P22 Kn469 sieA44 m44 (see Fig. 8).
Recombinant phage from these crosses were selected and linkage
of the amber mutations to the mutations responsible for their
altered plating properties was determined.
The recombinant phage derived from 19am82 (gln) sr512
exhibited the secondary phenotype (ability to plate on
additional suppressor strains) in 50 out of 50 plaques tested.
The plaque morphology of the reconstructed phages was the same
as that of original secondary site revertant phage isolated
and as the parental 19am phage. The reconstructed phage
der ved from 19am82 (gln) sr513 and 19am82 (gln) sr516 exhibited
the secondary phenotype in 50 out of 50 plaques tested. For
these two phages , however there were two plaque morphologies
segregating in the crosses. In both cases there were normal
turbid plaques and hazy turbid plaques. The hazy turbid
plaques represented 20% of the recombinants. The hazy
phenotype segregated independently from the secondary
phenotype. The original mutant phage bearing an amber
mutation in gene 19 and the secondary site revertant phage had
normal turbid plaques. It is possible that a mutation
elsewhere in the secondary site revertant phage influenced the
plaque morphology such that the hazy phenotype was masked.
Thus, the hazy mutation was only seen when crossed into a
clean background. To investigate this mutation further the
original mutant phage and the backcrossed phages (derived from
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the second site revertant phage) both the normal turbid and
the hazy turbid , were reverted on suppressor-minus cells and
compared to wild type. The plaques of the original amber
revertant, wild type , and the backcrossed normal turbid
revertant were identical but the backcrossed hazy revertant
maintained the hazy phenotype. I think that the hazy
phenotype mutation lies in gene 13 where other morphology
markers are known to occur. This was not investigated
further.
Recombinant phage were obtained for 19am22 (tyr) sr520
and 50 out of 50 plaques tested exhibited the secondary
phenotype.
Recombinant phage were obtained for 19am83 (tyr) sr532
and of the 50 plaques tested 46 exhibited the plating
phenotype of the secondary site revertant. This phage has a
ribosome binding site change which lies outside of the
deletion that is present on P22 Kn469
, therefore it was
expected that in this case the mutation responsible for the
secondary phenotype would segregate independently from the
amber mutation, although it is closely linked.
site phenotype was recovered 88% of the time.
The secondary
This is in very
good agreement with the position of the secondary site
mutation relative to the amount of homology present between
the phage and the plasmid. The phage and the plasmid have 305
bases of homology before the point of nonhomology starts
, the
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secondary site mutation is located at base 295. Thus the
secondary site mutation is 85% of distance from the start of
the homology. since this cross shows clearly that crossovers
can be detected , by examining 50 single plaque lysates
, when
they occur only 46 bases from the point of nonhomology and all
the secondary phages were sequenced beyond 50 bases from the
point of nonhomology, then I can conclude that the secondary
mutations responsible for the phenotypes observed in the other
backcrossed phage are the mutations that were wi thin gene 19.
I conclude that the changes present in gene 19 of
19am82 (gln) sr512 , 19am82 (gln) sr513 , 19am82 (gln) sr516 , and
19am22 (tyr) sr520 that were sequenced are responsible for the
abili ty to plate on the missuppressing strains.
Discussion
Amer suppression. The use of nonsense suppressors to
study proteins has a long history. Miller and co-workers in
1979 studied 400 mutant lac repressor proteins each with a
known amino acid substitution by using nonsense suppressors.
RNA polymerase subunit beta was studied in a like fashion by
Nene and Glass (1980). These studies yielded information
concerning the efficiency of suppression as a by-product. The
efficiency of suppression was found to be dependent not just
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upon the specific suppressor allele being used but also upon
the context in which the nonsense codon was found. Bossi
(1983) and Miller and Albertini (1983) studied context affects
of suppression in Salmonella and E. coli, respectively. The
resul ts were similar for suppressor tRNAs of both species.
Since the studies I am carrying out are done in Salmonella
will disscuss the results of Bossi. He examined the
eff iciencies of supD , supE , supF , and supJ , the amber
suppressors characterized and isolated by Winston et al.
(1979) . Bossi found a range of efficiencies for each of the
suppressors; supD ranged from 8. 4 % to 57. 3 %, supE 1 % to 20%,
supF 9. 5% to 79. 4%, and supJ from 14. 8% to 51. 9%. It was
found that the bases preceeding the amber codon had no effect
yet the base in the immediate 3' position correlated with
efficiencies. The lowest efficiencies result when the 3' base
is a C; an exception is when the triplet following the amber
is CUN where N stands for any base. The highest efficiencies
are seen when the 3' base is an A.
The efficiencies of suppression must be taken into
account when looking at missuppressed amber mutations and
isolating second site revertants. If a second site revertant
changed the codon following a missuppressed amber mutation
then the phenotype of the revertant could be due to a change
in the protein or a change in the efficiency of translation.
Of the eleven amber mutations used in this study six sites
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originally coded for amino acids for which suppressor tRNAs
are available. In all six cases the phage bearing the amber
mutations formed normal size plaques when grown in a
suppressor strain that inserted the wild type amino acid.
None of the eleven sites are followed by a 
Possible affects of the second site revertants. Of 25
combinations of P22 19am phage and suppressor strains that
resul t in less active lysozymes , revertants were isolated for
18 combinations. From over 4000 revertants screened, 82
secondary site revertants were isolated. Of these 82
secondary site revertants , 10 were fully characterized.
By examining the suppression tables of the phage
bearing the primary amber mutations to see how many
combinations of phage and suppressor strains could
theoretically yeild second site revertants and then comparing
this to the combinations for which second site revertants were
actually isolated , it becomes apparent that secondary site
mutations are extremely rare , and for some combinations , were
not obtainable. Second site revertants proved to be the most
difficul t to isolate from the mutant phages that exhibited the
most severe defects on a particular suppressor stra
, ,
such
that the the titers were the same on the suppressor strain as
on the suppressor-minus strain. The combinations of mutant
phage and suppressor that were moderately defective yielded
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the most secondary site revertants. The combinations that
resulted in a mild defect were difficult to work with and the
numbers of revertants screened was too low to judge the
frequency of isolating secondary site revertants.
Putative regulatory mutations accounted for 4 of the
secondary site mutations. All of these were in the area of
the gene 19 ribosome binding site. Due to the overlap of gene
13 and gene 19 all but one of these regulatory mutations also
caused amino acid changes in gene 13. It is therefore
difficult to say with certainty if the increase in plating
ability is due to a change in gene 13 gene product or an
increase in translation of gene It is known that
increasing the rate of translation of T4 gene e in a hybrid
P22 phage can allow some missuppressed amber mutants to form
plaques (Knight et al.
, 1987). This can be due to a greater
amount of a less efficient lysozyme as seen when the phage is
grown on a missuppressing strain. The absolute amount of
. translation increases so the absolute amount of read-though of
the amber mutation increases even though the ratio of read-
though to termination and suppression stays the same. This
leads to more lysozyme being produced even though the amino
acid at the position of the amber mutation is not known. This
effect can be seen when phage bearing amber mutations is grown
on a suppressor-minus strain (Knight et al. , 1987). It is not
--- 
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thought that gene 19 is translationally regulated as is the
case of T4 gene e. Yet a better ribosome binding site could
conceivably increase the amount of translation. I tried to
see if this was the case by radiolabeling protein synthesized
during phage infection and comparing amount of lysozyme
synthesized. P22 lysozyme migrates with a host band during
electrophoresis and is not readily quantified this way.
One secondary site mutation that mapped near the
ribosome binding site did not cause an amino acid change in
gene 13 , and yet it still suppressed the missuppressed amber
mutation. P22 9am39 (val) sr575 has a CGC-~CGT (Arg-~Arg)
change. The rest of the regulatory mutants share the same
change GCC-~ACC (Ala-~Thr). These changes do not seem to
bring the sequence closer to a consensus ribosome binding site
(see Fig. 9).
The secondaries that show no change in gene 
9am22 (tyr) sr517 and 19am82 (tyr) sr515) are less obvious.
These indicate that some change in P22 can compensate for a
less efficient lysozyme. Since it is thought that the P22
lysozyme acts independently, I do not think it is in a. protein
that interacts directly with lysozyme
, but rather a
consequence of a mutation that indirectly affects the level of
lysozyme made. P22 probably does not have an accessory lysis
gene analogous to the RZ gene of phage lambda (Garret and
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Young, 1982). P22 deletion mutants have been created that
delete sequences downstream of gene 19. These deletions have
no effect under a variety of plating conditions on the plaque-
forming ability of P22 (A. Poteete , personal communication).
Since P22 genes related by function are arranged in clusters
it seems unlikely that an accessory lysis gene would map far
from genes 3 and 19. It is more likely that the mutation is
one that increases transcription from P
Late by changing the
promoter or by destroying a terminator such as t
l or t2 so
that P
Late transcript can be made earlier than normal.
could be a mutation that increases the stability of the 
mRA.
The same type of extragenic non-ribosome binding site
secondary site mutations have been found by 
L. Hardy in our
laboratory for a P22 T4e hybrid phage. He is in the process
of mapping these. To date , it is known that the extragenic
mutations in these phages do not map between P
Late and gene
19.
The second site mutations in gene 19 might be of two
different types. One type would be a "global suppressor"
(Shortle et al. , 1986). A global suppressor is thought to be
a change which increases the stability of the protein. This
type of mutation is non-allele specific , suppressing many
different primary mutations. The other type of mutation would
be an allele specific suppressor that made a compensatory
change in the protein I s structure to accommodate the primary
mutation. There could be two types of allelic specific
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suppressors; one that affects the final structure or one that
affects an interaction present only in a folding 
intermediate.
It is likely that the 9am22 (tyr) sr520 is an allele specific
suppressor that affects the final structure of 
lysozyme. The
revertants 19am82 (gln) sr512 , 19am82 (gln) 513
, and
9am82 (gln) 516 could be global suppressors or allelic specific
i):.
suppressors that effect either the final structure or a
folding intermediate. I do not have any indication what type
of mutation these are from their postulated position in the
three dimensional structure.
. .
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APPENDIX
Mutagenesis. The UV mutagenesis was monitored in a
variety of ways. The formation of clear mutants and the
increase in the reversion rate of amber mutations were
indications of the degree of mutagenesis.
The degree of
reactivation of UV-irradiated phage was used to follow the
induction of mucA and mucB transcribed from pKM101 present in
the suppressor strains. The fall in phage titer after UV-
irradiation was also used to monitor the degree of
mutagenesis.
The induction of the PKM101-bearing strains was
accomplished by a growing the strains in minimal 
dium plus
antibiotics until a cell density of 1 x 10 /ml was attained.
At that point 5 ml would be placed in the bottom of a glass
petri dish and exposed to UV light for 10 
seconds. Thedistance and light I used delivered 300 ergs/mr 
when the
exposure was 10 seconds. The cells were then used directly
for infection with UV-irradiated phage. The infections were
performed by adding the phage to be tested to 0.
5 ml of
cul ture in a glass tube
, letting the phage adsorb for 20
minutes , then adding 5 ml of non UV-irradiated cells that were
at a cell density of 2 x 10 /ml. The cells were then plated
by adding 2. 5 ml of soft agar and pouring the mixture onto
lambda plates. I found that if the cells to be UV stimulated
were at higher density I did not see as much reactivation of
--.~~~""""
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This table show the increase in reversion frequenCY
an amber mutation after UV treatment. strains TP279 (tyr) and
TP278 (gln) carry the pKM101 plasmid and the cells were UV
stimulated before infection. TP279 (tyr) strain missuppresses
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UV-irradiated phage.
The tests to follow the mutagenesis were not performed
for every phage but were usually performed for one phage per
experiment. A typical result is shown below.
P22 19am82 (gln) to the same degree as an Su-
. The TP278 (gln)
suppressor strain inserts the original amino acid for
19am82 (gln) 
nonpermissi ve permissive reversion freq.
allele TP279 (tyr)
1 x 10
TP278 (gIn)
1 x 1019am82 (gln)
19am82 (gln) (UV) 2 x 10 1 x 10
The table below shows killing, and reactivation of UV
treated phage. All the suppressor strains insert the original am
acid. The suppressor tRNA from MS1363 
(gln) was transduced into an
su- strain bearing pKM101 to create TP278 (gIn) . In this particul
experiment killing was 4 logs as jUdged by the plating on
MS1363 (gln) The reactivation was 30 fold as indicated by the
titer of 
-the UV-irradiated phage on MS136 as compared to the
titer on TP278 (UV stimulated). There was some reactivation
even without induction of the 
muc system as indicated by the
increased titer on TP278 (gIn) .
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There were 4% clear plaques in th
("-1%).
19am82 (gIn) (UV) stock and no detectable clears in the 19am82 (gln
allele
19am82 (gln) 1 x 10
19am82 (gln) (UV) 1 x 10
1 x 10
4 x 10
1 x 10
3 x 10
Plasmids
pDR469
pTP399
pDR512
. ' ., ._ -._- ..==- - , . ..' - - '-- -'._ '.-
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TABLE 6
PLASMIDS
Ligation of 5. 04 kb HpaI fragment obtained from
pPB20::TN5-13 with pTP399
, which had been
prepared by digesting with HindIII and Bgl , andfilling in the ends generated by the digestions.
This construction replaces most of gene 19 with
TN5 DNA.
This plasmid contains DNA from three sources: An
origin of replication containing fragment derived
from pZ152 (Zagusky and Berman , 1984) (PvII-EcoRI) ligated
to P22 DNA that includes DNA from a 
RsaI site (that
has been ligated with Sail linkers to the pZ152
filled-in EcoRI) in gene 
3 to the first DdeI sitein gene 19 (the first nine codons of gene 9).
This is followed with a HindIII linker, and T4 DNA that
encompasses the ribosome binding site of gene e and
all of gene e. This is followed by a 
BglII linker.
After the BglII linker, P22 DNA continues from 70 bp
from the end of gene 19 to a 
HpaI site 384 bases 
of gene 19. The HpaI site has been converted to a BamHI
site when ligated with BamHI linkers to PvII site of pZ152.
Plasmid used for backcrossing the mutant alleles to P22.Ligation of 1. 1 kb HpaI fragment of P22 am82sr512 with
EcoRV digested pBR322.
pDR513 This is the same construction as pDR512 except it containsP22 DNA from P22am82sr513.
pDR516 This is the same construction as pDR512 except it containsP22 DNA from P22am82sr516.
pDR520 This the same construction as pDR512 except it containsP22 DNA from P22am22sr520.
pDR5 3 2 This is the same construction as pDR512 except it contains
P22 DNA from P22am83sr532.
._. .
TABLE
Isolation of Revertants with Direct Plating
Missuppressing strains Revertants
allele/TP27 8/TP279 /TP2 8 0/TP2 82/TP3 08/TP3 09 /primary /secondary
Am12
Am22
Am39
Am80
Am82
Am83
350
350
350
100
100
100
100
750
600
500
350
200
Table 7. A summary of the isolation of revertants after uv-
irradiation and direct plating.
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Isolation of Revertants with "Cycling"
allele/su+
am22/TP278
am22/TP282
am82/TP278
am82/TP279
am82/TP282
am83/TP278
am8 3 /TP2 8 
Suppressor strains
TP278 TP2 7 9 TP280 TP282(gln) (tyr) (leu) (ser)
0/150 0/150
0/18 16/50
0/50 0/50
0/50
0/150 5/100
18/50 29/200
7/50 12/50
Table 8. A summary of revertants isolated from UV-irradiated
phage that were passaged through semi-
permissive su+ cells beforebeing plated on missuppressing 
strains. The phage allele isshown on the left with the strain used to passage the phage. Thenumbers shown are the numbers of secondary site revertants over
the number of revertants screened. The numbers are in thecolumns under the suppressor strain used for the platings.
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TABLE 9
SUPPRESSION PATTERNS OF SECOND SITE REVERTANTS
Inserted Amino AcidPhage Gln Tyr Leu Ser Phe Cys
am82 (gIn)
+/-
am82sr512
+/- +/-
am82sr513
am82sr514
am82sr516
am22 (tyr)
am22sr517
+/-
am22sr520
am39 (val)
am39sr575
am39sr581
am83 (tyr)
am83sr532
am83sr542
Table 9. Suppression patterns of parent and second site
revertant phage. The suppression strains used were TP278TP279 , TP2 , TP282 , TP308 , and TP309. The platings weredone at 37 C. The symols are; 
++ , normal plaque size andti ter; +
, pinpoint plaques and titer reduced by no more than
1000 fold; -
, titer reduced by greater than 1000 fold. Thetiters were standardized by titering on TP320. Plaque size- determinations are subjective 
comparisons of plaque size onthe most permissive strain for the given phage. * , indicatesslightly better plaque than + but not as good as 
++.
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Table 10. Sequence changes of second site revertants.
The
nucleotide changes found in the second site revertants of
missuppressed 19am phage are shown 
above. The allele number is
shown on the left. The nucleotide changes are shown in the next
col limn and the subsequent amino acid changes are shown in the
following column. The numbers represent codon numbers of gene 19
unless otherwise indicated.
i!..
"".
TABLE 10 134
SEQUENCE CHAGES OF SECOND SITE REVERTANTS
Nucleotide changes
Amino Acid changes
am82sr512 AAT TCT-~AA CCT42 TCA-~TTA ASN SER-~ LYS PRO42 43 42 SER-~LEU46 46 
arn82sr513 TCA-~TTA SER-~LEU46 
am82sr514 TCA-~TTA
SER-~LEU46 
arn82sr516 TCA-~TTA TCT-~ACT GAC-~GTC
128
arn22sr517 NONE
am22sr520 AGA CTA-~AGT TTA TCA-~AA
SER-~;LU23 SER-~THR56 ASP-~VAL128 128
ARG LEU-~SER LEU18 19 18 SER-~LYS23 
arn39sr575 CGC-~CGT
97 (GENE 13) ARG-~ARG97 (GENE 13)
am39sr581 GCC-~ACC
103 (GENE 13) ALA-~THR103 (GENE 13)
am83sr532 GCC-~ACC
103 (GENE 13) TTA-~TTG11 ALA -~THR103 (GENE 13) LEU-~LEU11 
. am83sr542 GCC-~ACC
 . 
103 (GENE 13)
If 
if-
ALA-~THR
103 (GENE 13)
-'-
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FIGURE 8
BACKCROSSING THE MUTANT ALLELES TO P22
plasmid gene 13 gene 19
HpaI
phage
prophage
:.:.:.:.:.:.:.:.:.:.:..:.:.:.:.:.:.:.:.:.:.:.
gene 13 Tn5 gene 19
305 bp- 386 bp
::!: ~~~~~~~~~~~~~~~~~~~~~
gene 13 gene 19
recombinant phage
Figure 8. The cross between P22Kn469 and pDR512-pDR520
series of plasmids. Non-homology between the plasmid and the
phage in gene 19 is represented by 
**. 
Gene 19 has been
deleted from the prophage between codon 9 and codon 123 and
substi tuted with a large insertion. The number of base pairs
available in each crossover interval are shown below the prophage
I' !
136FIGURE 9
RIBOSOME BINDING SITE MUTATIONS
Wild type P22 gene 19 ribosome binding site
3' HO A U U C C U C
AAA
-13 
C A C U A G.... . 16S
C G A G' A U G
rRNA
Wild type P22 gene 13 3' sequence
3' HOAUU CCU CCA CUA G.... . 16S rRNA-30 III IIIAA CGC UUC GCU GCU AA AA GCC GGA GUC GAU GAU GCA AAU CAG CAG UAA
. I 
. -----
----19 start
-25
-15
Fig. 9. Panel A. The sequence in the area of P22
ribosome binding site is shown below the sequence of the
3' end of the 16S rRNA. The presumed bases that pair aremarked. The secondary change found in 3 of the
regulatory mutants is designated below the P22 
sequence.Panel B. The 3' sequence of gene 13 is shown with the
start site and ribosome binding site of gene 19 indicated
by dashed lines. The secondary change that does not
change an amino acid in gene 13 is indicated below theline. The sequence was searched for possible stem and
loop structures and none were found that would involve
the changed base.
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CHAPTER V
CONCLUSIONS
The question "How does a protein attain and
maintain its tertiary structure as dictated by its amino
acid sequence?" has been a significant question asked by
biologists for decades (Anfinsen
, 1964). The work presented
in this thesis explores an approach to this question by
developing a system that examines defective proteins which
have compensating changes. Second site reversion has been
used as a method to study proteins for more than 20 years
but only in recent years with the technological advances
that have 'been made has it become feasible to do this on a
significant scale (Helinski and Yanofsky, 1963; Shortle and
Lin , 1986).
In this thesis I describe 11 amber mutations in P22 gene
19. All of the amber mutations created non-functional
truncated proteins when grown on su- strains ranging in
length from 12 residues to 122 residues. Using six
different suppressor tRNA strains it was possible to study
60 amino acid substitutions in P22 lysozyme. Of 60 amino
acid substitutions only 18 resulted in defective lysozymes.
This was not a surprising result since many investigators
have found that proteins exhibit a large degree of tolerance
to amino acid substitutions (Miller et al
, 1979; Perutz and
Lehmann , 1968; and Streisinger et al.
, 1966).
Amino acid substitutions that yield defective lysozymes
"'..,... . .._ .".,, '''
139
are not predictable by current methods (Chou and Fasman
1974; Schulz and Schirmer
, 1984). Tables 11 and 12 show how
the substituted amino acid at each residue position
, .
corresponds to exchange groups as defined by Schulz and
Schirmer or helix propensities as defined by Chou,
respectively . Nei ther index predicted which substitutions
would result in nonfunctional lysozyme. For instance at
position 61 where the original amino acid was glutamate
, the
substi tution of tyrosine yields a functional lysozyme when
both indexes would indicate that tyrosine would not
substitute well for glutamate; at position 82 where the
original amino acid was glutamine both indexes indicate that
serine would be a neutral substitution and yet it is a
detrimental one. The efficiencies of individual
substitutions must be determined empirically.
The missuppressed amber mutants were used to isolate
second site revertants. These revertants enable
interactions between amino acids to be mapped. The
relationships between the second site mutations and the
primary site mutations are not always apparent from the
posi tions of the mutations in the amino acid sequence. The
mutations must be mapped in context of the three dimensional
structure. Only in this way can one see the relationships
but even then the effects of the secondary change on the
primary mutation are not always readily apparent. The wild
type , mutant protein , and revertant protein should be
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diffraction patterns. This is an enormous 
task.
crystallized and the structures determined by x-
ray
If the wild
type protein has a known crystal structure then the changes
present in the structure of the revertant protein can be
Petsko , 1985).
predicted by modeling (eg. Ebright et al.
, 1984; Burley and
When the substitutions map near each other
on the three dimensional model it is sometimes possible to
envision how the affected residues interact by way of Van
der Waals forces or hydrogen bonding.
The difficulties come
when the mutations are distant from one 
another. To explain
the ability of one mutation to suppress the other one must
invoke totally different structures or changes transduced
long distances through the protein'
s backbone. Changes
transduced long distances have been seen in studies done
with single mutant T4 lysozymes 
(Alber et al.
, 1986). Most
mutant proteins that have had crystal structures solved
though show only very localized conformational changes
(Alber et al.
, 1987; and Matthews et al.
, 1987). other than
direct interaction between residues one can postulate that
the interaction does not take place in the final protein
during protein fOlding.
structure but is a transient interaction that takes place
since folding intermediates if they exist have not been
This is much harder to decipher
isolated except in cases where disulfide bonds are involved
(Beasty et al.
, 1986; Anderson and Welaufer
, 1976; and
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Freidman et al., 1966). A type of suppressor which is not
allele specific has been characterized; global suppressors
are changes which do not interact directly with the primary
mutation but increase the overall stability of the protein
thereby suppressing a defect which resulted in an unstable
protein. Shortle and Lin (1986) isolated and characterized
mutations of this kind for Staph A nuclease.
Since the structure of P22 lysozyme has not yet been
solved, it is difficult to interpret the second site
mutations. Some information is available though , since it
is postulated that the structure of P22 lysozyme will be
very similar to that of T4 lysozyme (Weaver et al. , 1986).
If we examine residues of T4 lysozyme that correspond to
residues of P22 lysozyme we can determine if they are
predicted to be close enough in the tertiary structure of
the protein to have an effect on one another. Figure 10
shows how the residues of T4 lysozyme line up with those of
P22 lysozyme. Figure 11 indicates the locations of the
mutations present in the second site revertants P22 19
am82 (gln) sr512 , 19am82 (gln) sr513 and 19am82 (gln) sr516
superimposed on the structure of T4 lysozyme. As shown the
revertants do not seem to interact directly with the primary
substi tution. They map on the opposite side of the molecule
in residues that are not predicted to have the same
conformation as in P22 lysozyme. These mutations might be
8t-
- - 
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global suppressor mutations which stabilize the protein
thereby increasing the activity of the mutant. These
particular mutations were not isolated in conjunction with
any other primary mutations. The experiments that would
answer whether these mutations are global would be to
isolate the second site mutations away from the primary site
mutation and then combine the second site mutations with
other primary site substitutions.
Also tability studies
should be done on purified lysozyme to see if the
temperature of denaturation has increased in the mutant
proteins.
The P22 9am82 (gln) sr512 mutation which has additional
changes as compared to the P22 19am82 (gln) sr513 demonstrates
that even if the ser -~ leu at residue 46 is a global
suppressor , the additional changes at residues 42 and 43
enables the phage to grow well at 40 C on serine suppressor
while the original change at position 46 does not. The P22
19am82 (gln) sr512 phage can also grow slightly on tyrosine
and phenylalanine- inserting suppressors while the P22
9am82 (gln) sr513 phage shows no growth. This could be a
case of additive global effects. Figure 12 shows the
location of the mutations present in second site revertant
P22 19am22 (tyr) sr520 , superimposed on the T4 lysozyme
structure. Since these changes map very close to the
original mutation on both the primary and tertiary structure
maps it is speculated that these changes represent allele
,,, , ' "'-':'"_."~~~~ " .
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specific suppression of the substitution at position 22.
appears that the two changes map on either side of a surface
loop.
Significance. The study described in this thesis was
designed to develop a system that would allow the
characterization of second site revertants of missuppressed
amber mutations. The system was set up so that amber
mutations could easily be created in any codon and
transferred to phage in a dependable manner. The subsequent
screening for second site revertants and isolation of
several demonstrates that this system is workable. When
this work was first undertaken it was hoped that the crystal
structure of P22 lysozyme would be 
solved. This has not
occurred as of yet
, even though it is currently being worked
on by Brian Matthews. Without the crystal structure
available it is difficult to draw conclusions about how the
mutations effect the structure of P22 lysozyme. Yet , the
work described here does have some significance since the
methods are currently being used to create amber mutations
in every codon of T4 lysozyme gene which is present in a 
P22
hybrid phage. Second site revertants isolated in that
system will be readily interpretable in terms of the three
dimensional structure. It is hoped that some further
understanding of how an amino acid sequence dictates
144
structure will come out of these studies.
It is more important today than ever before to
",'
understand how amino acid sequences determine structures
since with the molecular biology technologies available
genes could be designed to incorporate changes that would
make proteins more efficient or stable or even have unique
!J'
enzymatic properties if we could understand the relationship
between amino acid sequences and structures.
145Table
Amino Acid Substitutions Exchange Values
Substi tuted residue
gln tyr leu ser phe cys
original
residue
lys +;11 +;3 +;6 +;10 ; 3
tyr +; 137 +;6 +;3 +;66 ; 1
val +;9 +;3 +;15 +;9 +;7 ; 11
glu +;10 +; 1 +;6 +;11 +;3 +;5
gln +;21 +;2 +;6 +;11 +; 3 +;5
trp +;2 +; 1 +; 3 +;1 +;41 ; 1
gIn +;21 +;6 +; 11 ; 3
gIn +;21 +;6 ; 11
tyr +;2 +; 137 ; 6 ; 3 +;66 ; 1
gln 113 +;21 +; 2 +; 6 +; 11 +; 3 ; 5
trp 122 +;2 +; 1 +; 3 +; 1 +;41 ; 1
it'
Table 11. This table shows the exchange values for each amino
acid substitutions at the positions of the amber mutations. 
Theoriginal amino acid and codon numers are given on the left. Thesubsti tuted amino acids are shown across the top. The symols +and - indicate if there was any defect in the plating ability of
o phage bearing amber mutations on that suppressor strain at30 C. The number following gives a ratio; the probability that an
amino acid pair will Occur at a given position in proteins of
common ancestry divided by the probability that it will occur by
chance. All ratios are mutiplied by a factor of 10.
TABLE 12
Helix Propensities of Amino Acid Substitutions
Substi tuted residue
gln tyr leu ser phe cys
original
residue
lys , I + ih , I +ib + iH , I +ii
- ih , I
tyr , b
- ih , b +ib +iH +ii +ih
val , h + ih , h +ib +iH +ii +ih
glu +ih +ib +iH +ii +ih +ii
gln +ih +ib +iH +ii +ih +ii
trp, h +ih +ib +iH +ii +ih
gln +ih +iH +ii
gln , h +ih + iH , h
tyr , b +ih +ib iH, +ih
gln , h 113 +ih +ib +iH +ii +ih
trp, h 122 +ih +ib +iH +ii +ih
Table 12. This table shows the propensities of finding any given
amino acid in a helix. The original amino acid and codon numbers
are given on the left. The substituted amino acids are shown
across the top. The symols + and - indicate if there was anydefect in the plating abilit
of phage bearing amber mutations onthat suppressor strain at 30 C. The letter following representsHelical asssignments: H
, strong helix formeri h
, helix formeri Iweak helix formeri i, helix indifferenti b
, helix breakeri Bstrong helix breaker (Chou and Fasman
, 1974).
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::'1' FIGURE 10. The sequences are arranged for maximum sequence
homology. There are three gaps introduced into the P22
sequence: a 12 residue gap between 47 and 48
, a 5 residue gap
between 71 and 72
, and a 1 residue gap after 102. The
residue that show identity are underlined. The residues that
correspond to amber mutations are double underlined and residues
correspond to second site changes are in bold print.
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The locations of the mutations present in P22
19am82sr513 and 19am82sr516 are shown superimposed on the
structure of T4 lysozyme.
GIn
123
Glu
Sr SIb 
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Figure 
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Figure 12. The location of the mutations present P22
19am22sr520 are shown supreimposed on the structure of T4
lysozyme.
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